http://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMember0001979306--12-312025Q1http://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://andalusiancreditCompany.com/20250331#CapitalEquipmentMemberhttp://andalusiancreditCompany.com/20250331#KomlineSandersonGroupInc.Membertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://andalusiancreditCompany.com/20250331#CapitalEquipmentMemberhttp://andalusiancreditCompany.com/20250331#KomlineSandersonGroupInc.Membertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://andalusiancreditCompany.com/20250331#CapitalEquipmentMemberhttp://andalusiancreditCompany.com/20250331#KomlineSandersonGroupInc.Membertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://andalusiancreditCompany.com/20250331#AllworthFinancialGroupL.p.Membertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://andalusiancreditCompany.com/20250331#AllworthFinancialGroupL.p.Membertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://andalusiancreditCompany.com/20250331#StrategycorpsLlcMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://andalusiancreditCompany.com/20250331#StrategycorpsLlcMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://andalusiancreditCompany.com/20250331#StrategycorpsLlcMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://andalusiancreditCompany.com/20250331#AccessionRiskManagementGroupInc.Membertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://andalusiancreditCompany.com/20250331#WorldInsuranceAssociatesLlcMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://andalusiancreditCompany.com/20250331#GivingHomeHealthCareMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://andalusiancreditCompany.com/20250331#PediatricHomeRespiratoryServicesLlcMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://andalusiancreditCompany.com/20250331#PediatricHomeRespiratoryServicesLlcMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://andalusiancreditCompany.com/20250331#PediatricHomeRespiratoryServicesLlcMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://andalusiancreditCompany.com/20250331#DiversifiedAndProductionMediaSectorMemberhttp://andalusiancreditCompany.com/20250331#TouchtunesMusicGroupLlcMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://andalusiancreditCompany.com/20250331#HighTechIndustriesSectorMemberhttp://andalusiancreditCompany.com/20250331#OnezeroMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://andalusiancreditCompany.com/20250331#HighTechIndustriesSectorMemberhttp://andalusiancreditCompany.com/20250331#OnezeroMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://andalusiancreditCompany.com/20250331#HighTechIndustriesSectorMemberhttp://andalusiancreditCompany.com/20250331#OnezeroMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#RetailSectorMemberhttp://andalusiancreditCompany.com/20250331#NpmFranchisingLlcMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#RetailSectorMemberhttp://andalusiancreditCompany.com/20250331#NpmFranchisingLlcMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://andalusiancreditCompany.com/20250331#BusinessServicesSectorMemberhttp://andalusiancreditCompany.com/20250331#IntegrityMarketingAcquisitionLlcMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://andalusiancreditCompany.com/20250331#BusinessServicesSectorMemberhttp://andalusiancreditCompany.com/20250331#SafebuiltLlcMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#TransportationSectorMemberhttp://andalusiancreditCompany.com/20250331#A.StuckiCompanyMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#TransportationSectorMemberhttp://andalusiancreditCompany.com/20250331#A.StuckiCompanyMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://andalusiancreditCompany.com/20250331#CapitalEquipmentMemberhttp://andalusiancreditCompany.com/20250331#KomlineSandersonGroupInc.Membertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://andalusiancreditCompany.com/20250331#CapitalEquipmentMemberhttp://andalusiancreditCompany.com/20250331#KomlineSandersonGroupInc.Membertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://andalusiancreditCompany.com/20250331#CapitalEquipmentMemberhttp://andalusiancreditCompany.com/20250331#KomlineSandersonGroupInc.Membertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://andalusiancreditCompany.com/20250331#AllworthFinancialGroupL.p.Membertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://andalusiancreditCompany.com/20250331#AllworthFinancialGroupL.p.Membertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://andalusiancreditCompany.com/20250331#StrategycorpsLlcMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://andalusiancreditCompany.com/20250331#StrategycorpsLlcMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://andalusiancreditCompany.com/20250331#StrategycorpsLlcMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://andalusiancreditCompany.com/20250331#AccessionRiskManagementGroupInc.Membertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://andalusiancreditCompany.com/20250331#WorldInsuranceAssociatesLlcMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://andalusiancreditCompany.com/20250331#GivingHomeHealthCareMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://andalusiancreditCompany.com/20250331#PediatricHomeRespiratoryServicesLlcMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://andalusiancreditCompany.com/20250331#PediatricHomeRespiratoryServicesLlcMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://andalusiancreditCompany.com/20250331#PediatricHomeRespiratoryServicesLlcMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://andalusiancreditCompany.com/20250331#DiversifiedAndProductionMediaSectorMemberhttp://andalusiancreditCompany.com/20250331#TouchtunesMusicGroupLlcMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://andalusiancreditCompany.com/20250331#HighTechIndustriesSectorMemberhttp://andalusiancreditCompany.com/20250331#OnezeroFinancialSystemsLlcMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://andalusiancreditCompany.com/20250331#HighTechIndustriesSectorMemberhttp://andalusiancreditCompany.com/20250331#OnezeroFinancialSystemsLlcMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://andalusiancreditCompany.com/20250331#HighTechIndustriesSectorMemberhttp://andalusiancreditCompany.com/20250331#OnezeroFinancialSystemsLlcMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://andalusiancreditCompany.com/20250331#BusinessServicesSectorMemberhttp://andalusiancreditCompany.com/20250331#ImagefirstHoldingsLlcMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://andalusiancreditCompany.com/20250331#BusinessServicesSectorMemberhttp://andalusiancreditCompany.com/20250331#IntegrityMarketingAcquisitionLlcMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://andalusiancreditCompany.com/20250331#BusinessServicesSectorMemberhttp://andalusiancreditCompany.com/20250331#SafebuiltLlcMembertruetruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://andalusiancreditCompany.com/20250331#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://andalusiancreditCompany.com/20250331#FirstLienTermLoanMemberhttp://andalusiancreditCompany.com/20250331#FirstLienTermLoanMemberhttp://andalusiancreditCompany.com/20250331#MeasurementInputTransactionPriceMemberhttp://fasb.org/us-gaap/2024#MeasurementInputDiscountRateMemberhttp://andalusiancreditCompany.com/20250331#MeasurementInputTransactionPriceMemberhttp://fasb.org/us-gaap/2024#MeasurementInputDiscountRateMemberfalse0001979306us-gaap:RetainedEarningsMember2025-03-310001979306us-gaap:AdditionalPaidInCapitalMember2025-03-310001979306us-gaap:RetainedEarningsMember2024-12-310001979306us-gaap:AdditionalPaidInCapitalMember2024-12-310001979306us-gaap:RetainedEarningsMember2024-03-310001979306us-gaap:AdditionalPaidInCapitalMember2024-03-310001979306us-gaap:RetainedEarningsMember2023-12-310001979306us-gaap:AdditionalPaidInCapitalMember2023-12-310001979306none:UnregisteredSalesOfEquitySecuritiesMember2025-03-310001979306none:UnregisteredSalesOfEquitySecuritiesMember2025-03-030001979306none:UnregisteredSalesOfEquitySecuritiesMember2024-12-020001979306none:UnregisteredSalesOfEquitySecuritiesMember2024-09-030001979306none:UnregisteredSalesOfEquitySecuritiesMember2024-04-150001979306none:UnregisteredSalesOfEquitySecuritiesMember2024-02-130001979306none:UnregisteredSalesOfEquitySecuritiesMember2023-11-140001979306none:UnregisteredSalesOfEquitySecuritiesMember2023-06-300001979306none:UnregisteredSalesOfEquitySecuritiesMember2025-03-032025-03-030001979306none:PlacementAgentFeesMember2025-01-012025-03-310001979306none:UnregisteredSalesOfEquitySecuritiesMember2024-12-022024-12-020001979306none:UnregisteredSalesOfEquitySecuritiesMember2024-09-032024-09-030001979306none:UnregisteredSalesOfEquitySecuritiesMember2024-04-152024-04-150001979306none:UnregisteredSalesOfEquitySecuritiesMember2024-02-132024-02-130001979306none:PlacementAgentFeesMember2024-01-012024-03-310001979306none:UnregisteredSalesOfEquitySecuritiesMember2023-11-142023-11-140001979306none:UnregisteredSalesOfEquitySecuritiesMember2023-06-302025-03-310001979306none:UnregisteredSalesOfEquitySecuritiesMember2023-06-302023-06-300001979306us-gaap:RelatedPartyMember2025-03-310001979306us-gaap:RelatedPartyMember2024-12-310001979306none:SeniorSecuredRevolvingCreditFacilityMember2024-02-122024-02-120001979306none:SeniorSecuredRevolvingCreditFacilityMember2025-03-310001979306none:SeniorSecuredRevolvingCreditFacilityMember2024-12-310001979306none:SeniorSecuredRevolvingCreditFacilityMember2024-02-120001979306none:FirstLienTermLoanMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:IncomeApproachValuationTechniqueMember2025-03-310001979306none:FirstLienTermLoanMembernone:MeasurementInputTransactionPriceMemberus-gaap:ValuationTechniqueMatrixPricingMember2025-03-310001979306none:FirstLienTermLoanMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:IncomeApproachValuationTechniqueMember2024-12-310001979306none:FirstLienTermLoanMembernone:MeasurementInputTransactionPriceMemberus-gaap:ValuationTechniqueMatrixPricingMember2024-12-310001979306us-gaap:TransportationSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMemberus-gaap:DebtSecuritiesMember2025-03-310001979306us-gaap:RetailSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMemberus-gaap:DebtSecuritiesMember2025-03-310001979306us-gaap:InsuranceSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMemberus-gaap:DebtSecuritiesMember2025-03-310001979306us-gaap:HealthcareSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMemberus-gaap:DebtSecuritiesMember2025-03-310001979306us-gaap:FinancialServicesSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMemberus-gaap:DebtSecuritiesMember2025-03-310001979306none:HighTechIndustriesSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMemberus-gaap:DebtSecuritiesMember2025-03-310001979306none:DiversifiedAndProductionMediaSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMemberus-gaap:DebtSecuritiesMember2025-03-310001979306none:CapitalEquipmentMemberus-gaap:InvestmentUnaffiliatedIssuerMemberus-gaap:DebtSecuritiesMember2025-03-310001979306none:BusinessServicesSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMemberus-gaap:DebtSecuritiesMember2025-03-310001979306none:FirstLienTermLoanMember2025-03-310001979306us-gaap:InsuranceSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMemberus-gaap:DebtSecuritiesMember2024-12-310001979306us-gaap:HealthcareSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMemberus-gaap:DebtSecuritiesMember2024-12-310001979306us-gaap:FinancialServicesSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMemberus-gaap:DebtSecuritiesMember2024-12-310001979306none:HighTechIndustriesSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMemberus-gaap:DebtSecuritiesMember2024-12-310001979306none:DiversifiedAndProductionMediaSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMemberus-gaap:DebtSecuritiesMember2024-12-310001979306none:CapitalEquipmentMemberus-gaap:InvestmentUnaffiliatedIssuerMemberus-gaap:DebtSecuritiesMember2024-12-310001979306none:BusinessServicesSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMemberus-gaap:DebtSecuritiesMember2024-12-310001979306us-gaap:InvestmentUnaffiliatedIssuerMemberus-gaap:DebtSecuritiesMember2024-12-310001979306none:FirstLienTermLoanMember2024-12-310001979306World Insurance Associates, LLC, Debt investments, First Lien Term Loan2025-01-012025-03-310001979306Touchtunes Music Group, LLC, Debt investments, First Lien Term Loan2025-01-012025-03-310001979306StrategyCorps, LLC, Debt investments, First Lien Term Loan2025-01-012025-03-310001979306StrategyCorps, LLC, Debt investments, First Lien Revolving Loan2025-01-012025-03-310001979306StrategyCorps, LLC, Debt investments, First Lien Delayed Draw Term Loan2025-01-012025-03-310001979306SAFEbuilt, LLC, Debt investments, First Lien Term Loan2025-01-012025-03-310001979306Pediatric Home Respiratory Services, LLC, Debt investments, First Lien Term Loan2025-01-012025-03-310001979306Pediatric Home Respiratory Services, LLC, Debt investments, First Lien Revolving Loan2025-01-012025-03-310001979306Pediatric Home Respiratory Services, LLC, Debt investments, First Lien Delayed Draw Term Loan2025-01-012025-03-310001979306OneZero, Debt investments, First Lien Term Loan2025-01-012025-03-310001979306OneZero, Debt investments, First Lien Revolving Loan2025-01-012025-03-310001979306OneZero, Debt investments, First Lien Delayed Draw Term Loan2025-01-012025-03-310001979306NPM Franchising, LLC, Debt investments, First Lien Term Loan2025-01-012025-03-310001979306NPM Franchising, LLC, Debt investments, First Lien Revolving Loan2025-01-012025-03-310001979306Komline-Sanderson Group, Inc., Debt Investments, First Lien Term Loan2025-01-012025-03-310001979306Komline-Sanderson Group, Inc., Debt Investments, First Lien Revolving Loan2025-01-012025-03-310001979306Komline-Sanderson Group, Inc., Debt Investments, First Lien Delayed Draw Term Loan2025-01-012025-03-310001979306ImageFirst Holdings, LLC, Debt investments, First Lien Term Loan2025-01-012025-03-310001979306Giving Home Health Care, Debt investments, First Lien Term Loan2025-01-012025-03-310001979306Allworth Financial Group, L.P., Debt Investments, First Lien Revolving Loan2025-01-012025-03-310001979306Allworth Financial Group, L.P., Debt Investments, First Lien Delayed Draw Term Loan2025-01-012025-03-310001979306Accession Risk Management Group, Inc., Debt investments, First Lien Delayed Draw Term Loan2025-01-012025-03-310001979306A. Stucki Company, LLC, Debt investments, First Lien Term Loan2025-01-012025-03-310001979306A. Stucki Company, LLC, Debt investments, First Lien Delayed Draw Term Loan2025-01-012025-03-310001979306World Insurance Associates, LLC, Debt investments, First Lien Term Loan2024-01-012024-12-310001979306Touchtunes Music Group, LLC, Debt investments, First Lien Term Loan2024-01-012024-12-310001979306StrategyCorps, LLC, Debt investments, First Lien Term Loan2024-01-012024-12-310001979306StrategyCorps, LLC, Debt investments, First Lien Revolving Loan2024-01-012024-12-310001979306StrategyCorps, LLC, Debt investments, First Lien Delayed Draw Term Loan2024-01-012024-12-310001979306SAFEbuilt, LLC, Debt investments, First Lien Term Loan2024-01-012024-12-310001979306Pediatric Home Respiratory Services, LLC, Debt investments, First Lien Term Loan2024-01-012024-12-310001979306Pediatric Home Respiratory Services, LLC, Debt investments, First Lien Revolving Loan2024-01-012024-12-310001979306Pediatric Home Respiratory Services, LLC, Debt investments, First Lien Delayed Draw Term Loan2024-01-012024-12-310001979306oneZero Financial Systems, LLC, Debt investments, First Lien Term Loan2024-01-012024-12-310001979306oneZero Financial Systems, LLC, Debt investments, First Lien Revolving Loan2024-01-012024-12-310001979306oneZero Financial Systems, LLC, Debt investments, First Lien Delayed Draw Term Loan2024-01-012024-12-310001979306Komline-Sanderson Group, Inc., Debt Investments, First Lien Term Loan2024-01-012024-12-310001979306Komline-Sanderson Group, Inc., Debt Investments, First Lien Revolving Loan2024-01-012024-12-310001979306Komline-Sanderson Group, Inc., Debt Investments, First Lien Delayed Draw Term Loan2024-01-012024-12-310001979306Integrity Marketing Acquisition, LLC, Debt investments, First Lien Term Loan2024-01-012024-12-310001979306ImageFirst Holdings, LLC, Debt investments, First Lien Term Loan2024-01-012024-12-310001979306Giving Home Health Care, Debt investments, First Lien Term Loan2024-01-012024-12-310001979306Allworth Financial Group, L.P., Debt Investments, First Lien Revolving Loan2024-01-012024-12-310001979306Allworth Financial Group, L.P., Debt Investments, First Lien Delayed Draw Term Loan2024-01-012024-12-310001979306Accession Risk Management Group, Inc., Debt investments, First Lien Delayed Draw Term Loan2024-01-012024-12-310001979306us-gaap:InvestmentUnaffiliatedIssuerMemberus-gaap:DebtSecuritiesMember2025-03-310001979306us-gaap:RetainedEarningsMember2025-01-012025-03-310001979306us-gaap:RetainedEarningsMember2024-01-012024-03-310001979306us-gaap:MeasurementInputDiscountRateMember2025-03-310001979306none:MeasurementInputTransactionPriceMember2025-03-310001979306us-gaap:MeasurementInputDiscountRateMember2024-12-310001979306none:MeasurementInputTransactionPriceMember2024-12-310001979306srt:WeightedAverageMembernone:FirstLienTermLoanMemberus-gaap:ValuationTechniqueMatrixPricingMember2025-03-310001979306srt:WeightedAverageMembernone:FirstLienTermLoanMemberus-gaap:IncomeApproachValuationTechniqueMember2025-03-310001979306srt:MinimumMembernone:FirstLienTermLoanMemberus-gaap:ValuationTechniqueMatrixPricingMember2025-03-310001979306srt:MinimumMembernone:FirstLienTermLoanMemberus-gaap:IncomeApproachValuationTechniqueMember2025-03-310001979306srt:MaximumMembernone:FirstLienTermLoanMemberus-gaap:ValuationTechniqueMatrixPricingMember2025-03-310001979306srt:MaximumMembernone:FirstLienTermLoanMemberus-gaap:IncomeApproachValuationTechniqueMember2025-03-310001979306srt:WeightedAverageMembernone:FirstLienTermLoanMemberus-gaap:ValuationTechniqueMatrixPricingMember2024-12-310001979306srt:WeightedAverageMembernone:FirstLienTermLoanMemberus-gaap:IncomeApproachValuationTechniqueMember2024-12-310001979306srt:MinimumMembernone:FirstLienTermLoanMemberus-gaap:ValuationTechniqueMatrixPricingMember2024-12-310001979306srt:MinimumMembernone:FirstLienTermLoanMemberus-gaap:IncomeApproachValuationTechniqueMember2024-12-310001979306srt:MaximumMembernone:FirstLienTermLoanMemberus-gaap:ValuationTechniqueMatrixPricingMember2024-12-310001979306srt:MaximumMembernone:FirstLienTermLoanMemberus-gaap:IncomeApproachValuationTechniqueMember2024-12-310001979306us-gaap:CommonStockMember2025-01-012025-03-310001979306us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310001979306us-gaap:CommonStockMember2024-01-012024-03-310001979306us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001979306World Insurance Associates, LLC, Debt investments, First Lien Term Loan2025-03-310001979306Touchtunes Music Group, LLC, Debt investments, First Lien Term Loan2025-03-310001979306StrategyCorps, LLC, Debt investments, First Lien Term Loan2025-03-310001979306StrategyCorps, LLC, Debt investments, First Lien Revolving Loan2025-03-310001979306StrategyCorps, LLC, Debt investments, First Lien Delayed Draw Term Loan2025-03-310001979306SAFEbuilt, LLC, Debt investments, First Lien Term Loan2025-03-310001979306Pediatric Home Respiratory Services, LLC, Debt investments, First Lien Term Loan2025-03-310001979306Pediatric Home Respiratory Services, LLC, Debt investments, First Lien Revolving Loan2025-03-310001979306Pediatric Home Respiratory Services, LLC, Debt investments, First Lien Delayed Draw Term Loan2025-03-310001979306OneZero, Debt investments, First Lien Term Loan2025-03-310001979306OneZero, Debt investments, First Lien Revolving Loan2025-03-310001979306OneZero, Debt investments, First Lien Delayed Draw Term Loan2025-03-310001979306NPM Franchising, LLC, Debt investments, First Lien Term Loan2025-03-310001979306NPM Franchising, LLC, Debt investments, First Lien Revolving Loan2025-03-310001979306Komline-Sanderson Group, Inc., Debt Investments, First Lien Term Loan2025-03-310001979306Komline-Sanderson Group, Inc., Debt Investments, First Lien Revolving Loan2025-03-310001979306Komline-Sanderson Group, Inc., Debt Investments, First Lien Delayed Draw Term Loan2025-03-310001979306ImageFirst Holdings, LLC, Debt investments, First Lien Term Loan2025-03-310001979306Giving Home Health Care, Debt investments, First Lien Term Loan2025-03-310001979306Allworth Financial Group, L.P., Debt Investments, First Lien Revolving Loan2025-03-310001979306Allworth Financial Group, L.P., Debt Investments, First Lien Delayed Draw Term Loan2025-03-310001979306Accession Risk Management Group, Inc., Debt investments, First Lien Delayed Draw Term Loan2025-03-310001979306A. Stucki Company, LLC, Debt investments, First Lien Term Loan2025-03-310001979306A. Stucki Company, LLC, Debt investments, First Lien Delayed Draw Term Loan2025-03-310001979306World Insurance Associates, LLC, Debt investments, First Lien Term Loan2024-12-310001979306Touchtunes Music Group, LLC, Debt investments, First Lien Term Loan2024-12-310001979306StrategyCorps, LLC, Debt investments, First Lien Term Loan2024-12-310001979306StrategyCorps, LLC, Debt investments, First Lien Revolving Loan2024-12-310001979306StrategyCorps, LLC, Debt investments, First Lien Delayed Draw Term Loan2024-12-310001979306SAFEbuilt, LLC, Debt investments, First Lien Term Loan2024-12-310001979306Pediatric Home Respiratory Services, LLC, Debt investments, First Lien Term Loan2024-12-310001979306Pediatric Home Respiratory Services, LLC, Debt investments, First Lien Revolving Loan2024-12-310001979306Pediatric Home Respiratory Services, LLC, Debt investments, First Lien Delayed Draw Term Loan2024-12-310001979306oneZero Financial Systems, LLC, Debt investments, First Lien Term Loan2024-12-310001979306oneZero Financial Systems, LLC, Debt investments, First Lien Revolving Loan2024-12-310001979306oneZero Financial Systems, LLC, Debt investments, First Lien Delayed Draw Term Loan2024-12-310001979306Komline-Sanderson Group, Inc., Debt Investments, First Lien Term Loan2024-12-310001979306Komline-Sanderson Group, Inc., Debt Investments, First Lien Revolving Loan2024-12-310001979306Komline-Sanderson Group, Inc., Debt Investments, First Lien Delayed Draw Term Loan2024-12-310001979306Integrity Marketing Acquisition, LLC, Debt investments, First Lien Term Loan2024-12-310001979306ImageFirst Holdings, LLC, Debt investments, First Lien Term Loan2024-12-310001979306Giving Home Health Care, Debt investments, First Lien Term Loan2024-12-310001979306Allworth Financial Group, L.P., Debt Investments, First Lien Revolving Loan2024-12-310001979306Allworth Financial Group, L.P., Debt Investments, First Lien Delayed Draw Term Loan2024-12-310001979306Accession Risk Management Group, Inc., Debt investments, First Lien Delayed Draw Term Loan2024-12-310001979306us-gaap:CashAndCashEquivalentsMember2025-01-012025-03-310001979306none:InvestmentUnaffiliatedMember2025-01-012025-03-310001979306us-gaap:CashAndCashEquivalentsMember2024-01-012024-03-310001979306none:InvestmentUnaffiliatedMember2024-01-012024-03-310001979306none:PriorToOccurrenceOfExchangeListingPreIncentiveFeeNetInvestmentIncomeDoesNotExceedHurdleAmountMemberus-gaap:RelatedPartyMember2025-03-310001979306none:AfterOccurrenceOfExchangeListingPreIncentiveFeeNetInvestmentIncomeDoesNotExceedHurdleAmountMemberus-gaap:RelatedPartyMember2025-03-310001979306none:FirstLienTermLoanMember2025-03-310001979306none:FirstLienTermLoanMember2024-12-310001979306none:FirstLienTermLoanMember2024-03-310001979306none:StrategycorpsLlcMembernone:FirstLienRevolvingLoanMember2025-03-310001979306none:StrategycorpsLlcMembernone:FirstLienDelayedDrawTermLoanMember2025-03-310001979306none:PediatricHomeRespiratoryServicesLlcMembernone:FirstLienRevolvingLoanMember2025-03-310001979306none:PediatricHomeRespiratoryServicesLlcMembernone:FirstLienDelayedDrawTermLoanMember2025-03-310001979306none:OnezeroMembernone:FirstLienRevolvingLoanMember2025-03-310001979306none:OnezeroMembernone:FirstLienDelayedDrawTermLoanMember2025-03-310001979306none:KomlineSandersonGroupInc.Membernone:FirstLienRevolvingLoanMember2025-03-310001979306none:KomlineSandersonGroupInc.Membernone:FirstLienDelayedDrawTermLoanMember2025-03-310001979306none:AllworthFinancialGroupL.pMembernone:FirstLienRevolvingLoanMember2025-03-310001979306none:AllworthFinancialGroupL.pMembernone:FirstLienDelayedDrawTermLoanMember2025-03-310001979306none:NpmFranchisingLlcMember2025-03-310001979306none:A.StuckiCompanyMember2025-03-310001979306none:StrategycorpsLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001979306none:StrategycorpsLlcMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001979306none:PediatricHomeRespiratoryServicesLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001979306none:PediatricHomeRespiratoryServicesLlcMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001979306none:OnezeroMembernone:FirstLienRevolvingLoanMember2024-12-310001979306none:OnezeroMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001979306none:KomlineSandersonGroupInc.Membernone:FirstLienRevolvingLoanMember2024-12-310001979306none:KomlineSandersonGroupInc.Membernone:FirstLienDelayedDrawTermLoanMember2024-12-310001979306none:AllworthFinancialGroupL.pMembernone:FirstLienRevolvingLoanMember2024-12-310001979306none:AllworthFinancialGroupL.pMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001979306none:SeniorSecuredRevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2024-02-122024-02-120001979306none:SeniorSecuredRevolvingCreditFacilityMemberus-gaap:BaseRateMember2024-02-122024-02-120001979306none:InvestmentsAtFairValueMembernone:IndustryConcentrationRiskMemberus-gaap:TransportationSectorMember2025-01-012025-03-310001979306none:InvestmentsAtFairValueMembernone:IndustryConcentrationRiskMemberus-gaap:RetailSectorMember2025-01-012025-03-310001979306none:InvestmentsAtFairValueMembernone:IndustryConcentrationRiskMemberus-gaap:InsuranceSectorMember2025-01-012025-03-310001979306none:InvestmentsAtFairValueMembernone:IndustryConcentrationRiskMemberus-gaap:HealthcareSectorMember2025-01-012025-03-310001979306none:InvestmentsAtFairValueMembernone:IndustryConcentrationRiskMemberus-gaap:FinancialServicesSectorMember2025-01-012025-03-310001979306none:InvestmentsAtFairValueMembernone:IndustryConcentrationRiskMemberus-gaap:CommercialAndIndustrialSectorMember2025-01-012025-03-310001979306none:InvestmentsAtFairValueMembernone:IndustryConcentrationRiskMembernone:DiversifiedAndProductionMediaSectorMember2025-01-012025-03-310001979306none:InvestmentsAtFairValueMembernone:IndustryConcentrationRiskMembernone:CapitalEquipmentMember2025-01-012025-03-310001979306none:InvestmentsAtFairValueMembernone:IndustryConcentrationRiskMembernone:BusinessServicesSectorMember2025-01-012025-03-310001979306country:USnone:InvestmentsAtFairValueMemberus-gaap:GeographicConcentrationRiskMember2025-01-012025-03-310001979306none:InvestmentsAtFairValueMemberus-gaap:GeographicConcentrationRiskMember2025-01-012025-03-310001979306none:InvestmentsAtFairValueMembernone:IndustryConcentrationRiskMember2025-01-012025-03-310001979306none:InvestmentsAtFairValueMembernone:IndustryConcentrationRiskMemberus-gaap:InsuranceSectorMember2024-01-012024-12-310001979306none:InvestmentsAtFairValueMembernone:IndustryConcentrationRiskMemberus-gaap:HealthcareSectorMember2024-01-012024-12-310001979306none:InvestmentsAtFairValueMembernone:IndustryConcentrationRiskMemberus-gaap:FinancialServicesSectorMember2024-01-012024-12-310001979306none:InvestmentsAtFairValueMembernone:IndustryConcentrationRiskMemberus-gaap:CommercialAndIndustrialSectorMember2024-01-012024-12-310001979306none:InvestmentsAtFairValueMembernone:IndustryConcentrationRiskMembernone:DiversifiedAndProductionMediaSectorMember2024-01-012024-12-310001979306none:InvestmentsAtFairValueMembernone:IndustryConcentrationRiskMembernone:CapitalEquipmentMember2024-01-012024-12-310001979306none:InvestmentsAtFairValueMembernone:IndustryConcentrationRiskMembernone:BusinessServicesSectorMember2024-01-012024-12-310001979306country:USnone:InvestmentsAtFairValueMemberus-gaap:GeographicConcentrationRiskMember2024-01-012024-12-310001979306none:InvestmentsAtFairValueMemberus-gaap:GeographicConcentrationRiskMember2024-01-012024-12-310001979306none:InvestmentsAtFairValueMembernone:IndustryConcentrationRiskMember2024-01-012024-12-310001979306us-gaap:CommonStockMember2025-03-310001979306us-gaap:CommonStockMember2024-12-310001979306us-gaap:CommonStockMember2024-03-310001979306us-gaap:CommonStockMember2023-12-3100019793062023-12-310001979306us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001979306us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001979306us-gaap:FairValueMeasurementsRecurringMember2025-03-310001979306us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001979306us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001979306us-gaap:FairValueMeasurementsRecurringMember2024-12-310001979306none:SeniorSecuredRevolvingCreditFacilityMember2025-01-012025-03-310001979306none:SeniorSecuredRevolvingCreditFacilityMember2024-01-012024-03-310001979306none:AdministratorMember2024-01-012024-03-310001979306none:FirstLienTermLoanMember2025-01-012025-03-310001979306none:FirstLienTermLoanMember2024-01-012024-03-310001979306none:AdministratorMember2025-01-012025-03-3100019793062022-10-172025-03-310001979306none:AdviserMember2025-01-012025-03-3100019793062024-03-310001979306none:PriorToLiquidityEventMemberus-gaap:RelatedPartyMember2025-01-012025-03-310001979306none:PostToLiquidityEventMemberus-gaap:RelatedPartyMember2025-01-012025-03-310001979306us-gaap:RelatedPartyMember2022-10-172025-03-310001979306none:PriorToOccurrenceOfExchangeListingPreIncentiveFeeNetInvestmentIncomeIfAnyThatExceedsHurdleAmountThresholdRateMemberus-gaap:RelatedPartyMember2025-01-012025-03-310001979306none:AfterOccurrenceOfExchangeListingPreIncentiveFeeNetInvestmentIncomeIfAnyThatExceedsHurdleAmountThresholdRateMemberus-gaap:RelatedPartyMember2025-01-012025-03-310001979306srt:MaximumMembernone:SeniorSecuredRevolvingCreditFacilityMember2024-12-132024-12-1300019793062024-01-012024-12-310001979306none:PriorToOccurrenceOfExchangeListingPreIncentiveFeeNetInvestmentIncomeIfAnyThatExceedsHurdleAmountButIsLessThanOrEqualToAmountThresholdRateMemberus-gaap:RelatedPartyMember2025-01-012025-03-310001979306none:AfterOccurrenceOfExchangeListingPreIncentiveFeeNetInvestmentIncomeIfAnyThatExceedsHurdleAmountButIsLessThanOrEqualToAmountThresholdRateMemberus-gaap:RelatedPartyMember2025-01-012025-03-310001979306us-gaap:RelatedPartyMember2025-01-012025-03-310001979306us-gaap:RelatedPartyMember2024-01-012024-03-3100019793062024-01-012024-03-310001979306none:AdministratorMember2025-03-3100019793062025-03-310001979306none:AdministratorMember2024-12-3100019793062024-12-3100019793062025-05-1400019793062025-01-012025-03-31xbrli:sharesiso4217:USDxbrli:pureiso4217:USDxbrli:sharesnone:component

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal quarter ended March 31, 2025

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 814-01670

ANDALUSIAN CREDIT COMPANY, LLC

(Exact Name of Registrant as Specified in its Charter)

Delaware
(State or other jurisdiction of
incorporation or organization)

92-2145091
(I.R.S. Employer
Identification No.)

 

 

40 West, 57th Street Suite 1700
New York, New York
(Address of principal executive offices)

10019
(Zip Code)

Registrant’s telephone number, including area code: (646) 989-4070

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

    

Trading Symbol(s)

    

Name of each exchange on which registered

None

None

None

Securities registered pursuant to Section 12(g) of the Act:

Shares of Limited Liability Company Interests, par value $0.001 per share.

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes  No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Small reporting company

Emerging growth company

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Yes No

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  No 

As of May 14, 2025, the registrant had 13,239,331 Shares, $0.001 par value per Share, outstanding.

Table of Contents

TABLE OF CONTENTS

Page

PART I. FINANCIAL INFORMATION

Item 1.

Financial Statements

Statements of Assets and Liabilities as of March 31, 2025 (Unaudited) and December 31, 2024

1

Statements of Operations for the three months ended March 31, 2025 and 2024 (Unaudited)

2

Statements of Changes in Net Assets for the three months ended March 31, 2025 and 2024 (Unaudited)

3

Statements of Cash Flows for the three months ended March 31, 2025 and 2024 (Unaudited)

4

Schedule of Investments as of March 31, 2025 (Unaudited) and December 31, 2024

5

Notes to Financial Statements (Unaudited)

9

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations.

24

Item 3.

Quantitative and Qualitative Disclosures About Market Risk.

34

Item 4.

Controls and Procedures

35

PART II. OTHER INFORMATION

36

Item 1.

Legal Proceedings.

36

Item 1A.

Risk Factors.

36

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

36

Item 3.

Defaults Upon Senior Securities.

36

Item 4.

Mine Safety Disclosures.

36

Item 5.

Other Information

37

Item 6.

Exhibits

38

Signatures

39

Table of Contents

Andalusian Credit Company, LLC

Statements of Assets and Liabilities

    

March 31, 2025

    

(unaudited)

December 31, 2024

Assets:

  

  

Investments in non-controlled non-affiliated investments, at fair value (cost $111,786,779 and $91,004,288, respectively)

$

111,635,774

$

91,188,202

Cash and cash equivalents

90,707,662

59,419,565

Interest receivable

 

1,190,694

 

913,083

Prepaid expenses and other assets

 

284,221

 

399,901

Total assets

$

203,818,351

$

151,920,751

Liabilities:

 

  

 

  

Management fees payable

$

1,547,910

$

1,520,781

Administration fees payable

 

317,443

 

316,040

Professional fees payable

 

232,150

 

151,000

Legal fees payable

 

115,265

 

73,755

Interest and credit facility fees payable (Note 6)

 

61,979

 

62,708

Due to affiliate

32,121

32,166

Accounts payable and accrued expenses

 

16,342

 

15,024

Total liabilities

$

2,323,210

$

2,171,474

Commitments and contingencies (Note 7)

 

  

 

  

Net assets:

 

  

 

  

Shares, par value $0.001 (13,239,331 and 9,863,357 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively)

$

13,239

$

9,863

Paid-in-capital in excess of par value

 

206,421,440

 

155,066,351

Distributable earnings (loss)

 

(4,939,538)

 

(5,326,937)

Total net assets

$

201,495,141

$

149,749,277

Total liabilities and net assets

$

203,818,351

$

151,920,751

Net asset value per share

$

15.22

$

15.18

The accompanying notes are an integral part of these financial statements.

1

Table of Contents

Andalusian Credit Company, LLC

Statements of Operations

(unaudited)

    

Three months

    

Three months

ended

ended

March 31, 2025

March 31, 2024 (1)

Investment Income:

Interest income from non-controlled/non-affiliated investments

$

2,638,849

$

162,438

Interest from cash and cash equivalents

685,477

65,816

Total investment income

3,324,326

228,254

Expenses:

  

  

Management fees

$

1,547,910

$

1,445,704

Professional fees

356,319

335,016

Administration fees

 

317,443

 

242,003

Interest expense and other financing costs

 

147,499

 

116,840

General and administrative expenses

125,337

126,273

Board fees

 

107,500

 

107,500

Offering expenses

319,799

Total operating expenses

 

2,602,008

 

2,693,135

Management fee waiver

 

 

(240,951)

Net operating expenses

 

2,602,008

 

2,452,184

Net investment income (loss)

 

722,318

 

(2,223,930)

Net change in unrealized appreciation (depreciation)

Net change in unrealized appreciation (depreciation) from non-controlled non-affiliated investments

(334,919)

Net change in unrealized appreciation (depreciation)

(334,919)

Net increase (decrease) in net assets resulting from operations

$

387,399

$

(2,223,930)

Per share data:

 

  

 

  

Net investment income (loss) per share

$

0.07

$

(3.35)

Net increase/(decrease) in net assets resulting from operations per share

$

0.04

$

(3.35)

Weighted average shares outstanding

 

10,951,171

 

664,051

(1)Certain items have been reclassified in prior quarters to conform with the current quarter presentation.

The accompanying notes are an integral part of these financial statements.

2

Table of Contents

Andalusian Credit Company, LLC

Statements of Changes in Net Assets

(unaudited)

Common Stock

    

Paid in Capital in

Distributable

    

Shares

    

Par Amount

    

Excess of Par

    

Earnings (Loss)

    

Total Net Assets

Balance at December 31, 2023

 

171,874

$

172

$

3,598,907

$

(2,658,163)

$

940,916

Operations:

 

Net investment income (loss)

 

(2,223,930)

(2,223,930)

Net increase (decrease) in net assets resulting from operations

 

(2,223,930)

(2,223,930)

Capital transactions:

 

Proceeds from issuance of shares

 

973,655

974

19,472,128

19,473,102

Net increase (decrease) in net assets resulting from capital share transactions

 

973,655

974

19,472,128

19,473,102

Total increase (decrease) for the three months ended March 31, 2024

 

973,655

974

19,472,128

(2,223,930)

17,249,172

Balance at March 31, 2024

 

1,145,529

$

1,146

$

23,071,035

$

(4,882,093)

$

18,190,088

Common Stock

    

Paid in Capital in

Distributable

    

Shares

    

Par Amount

    

Excess of Par

    

Earnings (Loss)

    

Total Net Assets

Balance at December 31, 2024

9,863,357

$

9,863

$

155,066,351

$

(5,326,937)

$

149,749,277

Operations:

Net investment income (loss)

722,318

722,318

Net change in unrealized appreciation (depreciation)

(334,919)

(334,919)

Net increase (decrease) in net assets resulting from operations

387,399

387,399

Capital transactions:

Proceeds from issuance of shares

3,375,974

3,376

51,355,089

51,358,465

Net increase (decrease) in net assets resulting from capital share transactions

3,375,974

3,376

51,355,089

51,358,465

Total increase (decrease) for the three months ended March 31, 2025

3,375,974

3,376

51,355,089

387,399

51,745,864

Balance at March 31, 2025

13,239,331

$

13,239

$

206,421,440

$

(4,939,538)

$

201,495,141

The accompanying notes are an integral part of these financial statements.

3

Table of Contents

Andalusian Credit Company, LLC

Statements of Cash Flows

(unaudited)

    

Three months

    

Three months

ended

ended

March 31, 2025

March 31, 2024

Cash flows from operating activities:

 

  

 

  

Net increase (decrease) in net assets resulting from operations

$

387,399

$

(2,223,930)

Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash (used in) provided by operating activities:

 

 

Purchases of investments

(28,045,502)

(19,820,356)

Proceeds from principal repayments

7,361,648

50,591

Net change in unrealized (appreciation) depreciation

334,919

Amortization of premium and accretion of discount, net

(98,637)

(10,510)

Amortization of deferred offering expenses

 

 

319,799

Amortization of deferred financing costs

81,874

70,778

Amortization of prepaid expenses

28,132

Changes in operating assets and liabilities:

 

 

Interest receivable

(277,611)

(172,095)

Prepaid expenses and other assets

 

5,674

 

(21,745)

Due from affiliate

 

 

17,413

Management fees payable

 

27,129

 

588,032

Professional fees payable

 

81,150

 

(41,250)

Organizational expenses payable

 

 

(132,327)

Administration fees payable

 

1,403

 

117,921

Legal fees payable

 

41,510

 

128,198

Interest and credit facility fees payable

(729)

Due to affiliate

 

(45)

 

Accounts payable and accrued expenses

 

1,318

 

(68,678)

Net cash provided by (used in) operating activities

 

(20,070,368)

 

(21,198,159)

Cash flows from financing activities:

 

 

Net proceeds from issuance of shares(1)

 

51,358,465

 

19,473,102

Offering expenses paid

 

 

(33,313)

Borrowings on debt

2,500,000

Deferred financing costs

(484,051)

Net cash provided by (used in) financing activities

 

51,358,465

 

21,455,738

Net increase in cash and cash equivalents

 

31,288,097

 

257,579

Cash and cash equivalents, beginning of period

 

59,419,565

 

1,011,952

Cash and cash equivalents, end of period

$

90,707,662

$

1,269,531

Supplemental and non-cash activities

 

  

 

Interest, including credit facility fees, paid during the period

$

66,354

$

(1)

Proceeds from the issuance of shares are presented net of placement agent fees of $128,211 and $48,491, respectively for the periods presented.

The accompanying notes are an integral part of these financial statements.

4

Table of Contents

Andalusian Credit Company, LLC

Schedule of Investments

As of March 31, 2025

(unaudited)

    

    

    

Reference

    

    

    

Par/

    

    

    

Percentage 

Rate and

Interest

Shares/

Amortized 

Fair 

of Net 

Company (1)

Footnotes

Investment

Spread

Rate

Maturity

 Units

Cost (2)(3)

Value (4)

Assets

Non-controlled non-affiliated investments

Debt investments

Capital Equipment

Komline-Sanderson Group, Inc.

(5)

First Lien Term Loan

S+

5.75

%  

10.05

%  

09/06/29

$

10,801,231

$

10,610,387

$

10,598,708

5.2

%

Komline-Sanderson Group, Inc.

(5)(6)

First Lien Delayed Draw Term Loan

S+

5.75

%  

10.05

%  

09/06/29

(46,145)

(97,854)

0.0

%

Komline-Sanderson Group, Inc.

(5)(6)

First Lien Revolving Loan

S+

5.75

%  

10.07

%  

09/06/29

(37,692)

(39,832)

0.0

%

10,526,550

10,461,022

5.2

%

FIRE: Finance

(7)

Allworth Financial Group, L.P.

 

(5)(6)

 

First Lien Delayed Draw Term Loan

 

S+

 

4.75

%  

9.28

%  

12/23/27

 

575,455

551,579

525,999

 

0.2

%

Allworth Financial Group, L.P.

 

(5)(6)

 

First Lien Revolving Loan

 

S+

 

4.75

%  

9.28

%

12/23/27

 

 

(2,231)

 

(2,613)

 

0.0

%

StrategyCorps, LLC

(5)

First Lien Term Loan

S+

5.25

%  

9.57

%

06/28/30

5,643,445

5,576,458

5,565,848

2.8

%

StrategyCorps, LLC

(5)(6)

First Lien Delayed Draw Term Loan

S+

5.25

%  

9.57

%

06/28/30

(7,278)

(31,274)

0.0

%

StrategyCorps, LLC

 

(5)(6)

 

First Lien Revolving Loan

 

S+

 

5.25

%  

9.57

%  

06/28/30

 

56,861

 

41,850

 

41,224

 

0.0

%

6,160,378

6,099,184

3.0

%

FIRE: Insurance

(7)

Accession Risk Management Group, Inc.

(5)

First Lien Delayed Draw Term Loan

S+

4.75

%  

9.05

%  

10/30/29

4,515,084

4,515,085

4,509,441

2.2

%

World Insurance Associates, LLC

(5)

First Lien Term Loan

S+

5.00

%  

9.30

%  

04/03/28

4,526,705

4,526,705

4,521,047

2.2

%

9,041,790

9,030,488

4.4

%

Healthcare & Pharmaceuticals

Giving Home Health Care

 

(5)

 

First Lien Term Loan

 

S+

 

5.75

%  

10.05

%  

04/26/29

 

8,302,849

8,159,908

8,178,306

 

4.1

%

Pediatric Home Respiratory Services, LLC

(5)

First Lien Term Loan

S+

5.50

%  

9.78

%  

12/23/30

13,953,601

13,886,473

13,883,834

6.9

%

Pediatric Home Respiratory Services, LLC

(5)(6)

First Lien Revolving Loan

S+

5.50

%  

9.78

%  

12/23/30

242,671

235,445

231,296

0.1

%

Pediatric Home Respiratory Services, LLC

(5)(6)

First Lien Delayed Draw Term Loan

S+

5.50

%  

9.78

%  

12/23/30

(6,414)

(13,650)

0.0

%

22,275,412

22,279,786

11.1

%

Media: Diversified & Production

Touchtunes Music Group, LLC

 

(5)

 

First Lien Term Loan

 

S+

 

4.75

%  

9.05

%  

04/01/29

 

4,514,756

4,514,756

4,480,895

 

2.2

%

4,514,756

4,480,895

2.2

%

High Tech Industries

OneZero

(5)

First Lien Term Loan

S+

5.00

%  

9.31

%  

10/07/31

5,249,634

5,201,314

5,203,700

2.6

%

OneZero

(5)(6)

First Lien Delayed Draw Term Loan

S+

5.00

%  

9.31

%  

10/07/31

309,728

305,548

301,690

0.1

%

OneZero

 

(5)(6)

 

First Lien Revolving Loan

 

S+

 

5.00

%  

9.31

%  

10/07/31

 

(6,110)

(6,562)

 

0.0

%

5,500,752

5,498,828

2.7

%

Retail

NPM Franchising, LLC

(5)

First Lien Term Loan

S+

5.50

%  

9.93

%  

01/13/29

10,920,210

10,715,905

10,715,905

5.3

%

NPM Franchising, LLC

(5)(6)

First Lien Revolving Loan

S+

5.50

%  

9.93

%  

01/13/29

(34,493)

(34,493)

0.0

%

10,681,412

10,681,412

5.3

%

Services: Business

Integrity Marketing Acquisition, LLC

(5)

First Lien Term Loan

S+

5.00

%  

9.31

%  

08/27/28

13,581,206

13,505,405

13,547,253

6.7

%

SAFEbuilt, LLC

 

(5)

 

First Lien Term Loan

 

S+

 

6.85

%  

11.17

%  

12/31/25

 

13,096,237

13,037,804

13,014,386

 

6.5

%

 

 

 

26,543,209

26,561,639

13.2

%

Transportation: Cargo

A. Stucki Company

(5)

First Lien Term Loan

S+

4.75

%  

9.31

%  

03/27/30

16,690,292

16,565,224

16,565,224

8.2

%

A. Stucki Company

(5)(6)

First Lien Delayed Draw Term Loan

S+

4.75

%  

9.31

%  

03/27/30

(22,704)

(22,704)

0.0

%

16,542,520

16,542,520

8.2

%

Total debt investments

 

 

 

111,786,779

111,635,774

55.3

%

Total non-controlled non-affiliated investments

 

 

 

111,786,779

111,635,774

55.3

%

Cash and cash equivalents

 

  

 

  

 

  

 

  

 

  

 

  

 

  

  

  

 

  

 

State Street Institutional U.S. Government Money Market Fund - Premier Class

 

(8)(9)

 

Money Market Fund

 

 

4.29

%  

  

90,386,298

90,386,298

 

44.9

%

Cash

 

 

Cash

 

 

  

 

  

 

  

321,364

321,364

 

0.2

%

Total cash and cash equivalents

 

 

 

  

 

  

 

  

 

  

90,707,662

90,707,662

 

45.1

%

Total investments and cash and cash equivalents

 

  

 

  

 

  

 

  

$

202,494,441

$

202,343,436

 

100.4

%

(1)Certain portfolio company investments are subject to contractual restrictions on sales.
(2)The amortized cost represents the original cost adjusted for the amortization of discounts and premiums, as applicable, on debt investments using the effective interest method.
(3)As of March 31, 2025, the estimated cost basis of investments for U.S. federal tax purposes was $202,494,441 resulting in estimated gross unrealized appreciation and depreciation of $62,632 and ($213,637), respectively.
(4)In accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 820, Fair Value Measurements (“ASC Topic 820”), unless otherwise indicated, the fair values of all investments were determined using significant unobservable inputs and are considered Level 3 investments. See Note 5 for further information related to investments at fair value.

5

Table of Contents

Andalusian Credit Company, LLC

Schedule of Investments

As of March 31, 2025

(unaudited)

(5)Investment contains a variable rate structure, subject to an interest rate floor. Variable rate investments bear interest at a rate that may be determined by reference to either the Secured Overnight Financing Rate (“S”) which may also contain a credit spread adjustment depending on the tenor election, or an alternate base rate (which can include the Federal Funds Effective Rate or the Prime Rate or “P”), all of which include an available tenor, selected at the borrower’s option, which reset periodically based on the terms of the credit agreement. For investments with multiple interest rate contracts, the interest rate shown is the weighted average interest rate in effect at March 31, 2025. As of March 31, 2025, the reference rate for our variable rate loans was SOFR at 4.32%.
(6)Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. The investment may be subject to an unused/letter of credit facility fee. The negative amortized cost or fair value is the result of the capitalized discount being greater than the principal amount outstanding on the loan which will be amortized into income.
(7)Finance, Insurance, and Real Estate (“FIRE”).
(8)This investment is valued using observable inputs and is considered a Level 1 investment. See Note 5 for further information related to investments at fair value.
(9)The rate presented represents the annualized seven-day yield as of March 31, 2025.

The accompanying notes are an integral part of these financial statements.

6

Table of Contents

Andalusian Credit Company, LLC

Schedule of Investments

As of December 31, 2024

    

    

    

Reference

    

    

    

Par/

    

    

    

Percentage 

Rate and

Interest

Shares/

Amortized 

Fair 

of Net 

Company (1)

Footnotes

Investment

Spread

Rate

Maturity

 Units

Cost (2)(3)

Value (4)

Assets

Non-controlled non-affiliated investments

Debt investments

Capital Equipment

Komline-Sanderson Group, Inc.

(5)

First Lien Term Loan

S+

5.75

%  

10.24

%  

09/06/29

$

10,828,370

$

10,627,752

$

10,627,752

7.1

%

Komline-Sanderson Group, Inc.

(5)(6)

First Lien Delayed Draw Term Loan

S+

5.75

%  

10.24

%  

09/06/29

(48,807)

(48,807)

0.0

%

Komline-Sanderson Group, Inc.

(5)(6)

First Lien Revolving Loan

S+

5.75

%  

10.24

%  

09/06/29

(39,776)

(39,776)

0.0

%

10,539,169

10,539,169

7.1

%

FIRE: Finance

(7)

Allworth Financial Group, L.P.

 

(5)(6)

 

First Lien Delayed Draw Term Loan

 

S+

 

5.00

%  

9.36

%  

12/23/27

 

105,745

79,408

79,408

 

0.1

%

Allworth Financial Group, L.P.

 

(5)(6)

 

First Lien Revolving Loan

 

S+

 

5.00

%  

9.36

%

12/23/27

 

 

(2,437)

 

(2,437)

 

0.0

%

StrategyCorps, LLC

(5)

First Lien Term Loan

S+

5.25

%  

9.61

%

06/28/30

5,657,660

5,586,055

5,615,228

3.7

%

StrategyCorps, LLC

(5)(6)

First Lien Delayed Draw Term Loan

S+

5.25

%  

9.61

%

06/28/30

(7,278)

(17,058)

0.0

%

StrategyCorps, LLC

 

(5)(6)

 

First Lien Revolving Loan

 

S+

 

5.25

%  

9.61

%  

06/28/30

 

 

(15,011)

 

(8,529)

 

0.0

%

5,640,737

5,666,612

3.8

%

FIRE: Insurance

(7)

Accession Risk Management Group, Inc.

(5)

First Lien Delayed Draw Term Loan

S+

4.75

%  

9.21

%  

10/30/29

4,526,617

4,526,617

4,526,616

3.0

%

World Insurance Associates, LLC

(5)

First Lien Term Loan

S+

6.00

%  

10.33

%  

04/03/28

4,526,705

4,526,705

4,526,705

3.0

%

9,053,322

9,053,321

6.0

%

Healthcare & Pharmaceuticals

Giving Home Health Care

 

(5)

 

First Lien Term Loan

 

S+

 

6.00

%  

10.62

%  

04/26/29

 

8,524,258

8,367,595

8,417,705

 

5.6

%

Pediatric Home Respiratory Services, LLC

(5)

First Lien Term Loan

S+

5.50

%  

9.78

%  

12/23/30

13,953,601

13,884,156

13,884,156

9.3

%

Pediatric Home Respiratory Services, LLC

(5)(6)

First Lien Delayed Draw Term Loan

S+

5.50

%  

9.78

%  

12/23/30

(6,786)

(6,786)

0.0

%

Pediatric Home Respiratory Services, LLC

(5)(6)

First Lien Revolving Loan

S+

5.50

%  

9.78

%  

12/23/30

242,671

235,122

235,122

0.2

%

22,480,087

22,530,197

15.1

%

Media: Diversified & Production

Touchtunes Music Group, LLC

 

(5)

 

First Lien Term Loan

 

S+

 

4.75

%  

9.08

%  

04/01/29

 

4,526,128

4,526,128

4,526,128

 

3.0

%

4,526,128

4,526,128

3.0

%

High Tech Industries

oneZero Financial Systems, LLC

(5)

First Lien Term Loan

S+

5.00

%  

9.59

%  

10/07/31

5,249,634

5,198,789

5,198,789

3.5

%

oneZero Financial Systems, LLC

(5)(6)

First Lien Delayed Draw Term Loan

S+

5.00

%  

9.59

%  

10/07/31

(4,449)

(4,449)

0.0

%

oneZero Financial Systems, LLC

 

(5)(6)

 

First Lien Revolving Loan

 

S+

 

5.00

%  

9.59

%  

10/07/31

 

(6,352)

(6,344)

 

0.0

%

5,187,988

5,187,996

3.5

%

Services: Business

ImageFirst Holdings, LLC

 

(5)

 

First Lien Term Loan

 

S+

 

4.25

%  

8.85

%  

04/27/28

 

7,005,036

6,999,991

7,005,036

 

4.7

%

Integrity Marketing Acquisition, LLC

(5)

First Lien Term Loan

S+

5.00

%  

9.51

%  

08/27/28

13,615,330

13,530,869

13,615,330

9.1

%

SAFEbuilt, LLC

 

(5)

 

First Lien Term Loan

 

S+

 

6.85

%  

11.19

%  

12/31/25

 

13,130,064

13,045,997

13,064,413

 

8.7

%

 

 

 

33,576,857

33,684,779

25.5

%

Total debt investments

 

 

 

91,004,288

91,188,202

64.0

%

Total non-controlled non-affiliated investments

 

 

 

91,004,288

91,188,202

64.0

%

Cash and cash equivalents

 

  

 

  

 

  

 

  

 

  

 

  

 

  

  

  

 

  

 

State Street Institutional U.S. Government Money Market Fund - Premier Class

 

(8)(9)

 

Money Market Fund

 

 

4.43

%  

  

58,868,006

58,868,006

 

39.3

%

Cash

 

 

Cash

 

 

  

 

  

 

  

551,559

551,559

 

0.4

%

Total cash and cash equivalents

 

 

 

  

 

  

 

  

 

  

59,419,565

59,419,565

 

39.7

%

Total investments and cash and cash equivalents

 

  

 

  

 

  

 

  

$

150,423,853

$

150,607,767

 

103.7

%

(1)Certain portfolio company investments are subject to contractual restrictions on sales.
(2)The amortized cost represents the original cost adjusted for the amortization of discounts and premiums, as applicable, on debt investments using the effective interest method.
(3)As of December 31, 2024, the estimated cost basis of investments for U.S. federal tax purposes was $150,423,853 resulting in estimated gross unrealized appreciation and depreciation of $193,695 and ($9,781), respectively.
(4)In accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 820, Fair Value Measurements (“ASC Topic 820”), unless otherwise indicated, the fair values of all investments were determined using significant unobservable inputs and are considered Level 3 investments. See Note 5 for further information related to investments at fair value.

7

Table of Contents

Andalusian Credit Company, LLC

Schedule of Investments

As of December 31, 2024

(5)Investment contains a variable rate structure, subject to an interest rate floor. Variable rate investments bear interest at a rate that may be determined by reference to either the Secured Overnight Financing Rate (“S”) which may also contain a credit spread adjustment depending on the tenor election, or an alternate base rate (which can include the Federal Funds Effective Rate or the Prime Rate or “P”), all of which include an available tenor, selected at the borrower’s option, which reset periodically based on the terms of the credit agreement. For investments with multiple interest rate contracts, the interest rate shown is the weighted average interest rate in effect at December 31, 2024. As of December 31, 2024, the reference rates for our variable rate loans was SOFR at 4.49%.
(6)Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. The investment may be subject to an unused/letter of credit facility fee. The negative amortized cost or fair value is the result of the capitalized discount being greater than the principal amount outstanding on the loan.
(7)Finance, Insurance, and Real Estate (“FIRE”).
(8)This investment is valued using observable inputs and is considered a Level 1 investment. See Note 5 for further information related to investments at fair value.
(9)The rate presented represents the annualized seven-day yield as of December 31, 2024.

The accompanying notes are an integral part of these financial statements.

8

Table of Contents

Andalusian Credit Company, LLC

Notes to Financial Statements

March 31, 2025

(unaudited)

Note 1. Organization

Andalusian Credit Company, LLC, a Delaware limited liability company (the “Company”), was formed on October 17, 2022 (“inception”). The Company is structured as an externally managed, closed-end management investment company. The Company has elected to be treated as a business development company (“BDC”) under the U.S. Investment Company Act of 1940, as amended (the “1940 Act”). In addition, the Company intends to elect to be treated as a regulated investment company (a “RIC”) for U.S. federal income tax purposes under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”) for the tax period ending December 31, 2025 and intends to maintain its qualification as a RIC annually thereafter. For periods prior to the effectiveness of the RIC election, the Company expects to be taxed as a corporation for U.S. federal income tax purposes. The Company commenced operations contemporaneously with the initial drawdown from investors in the Private Offering (as defined below) which occurred on November 14, 2023 (the “Initial Closing Date”).

The Company’s investment objective is to generate current income and capital appreciation by investing primarily in senior secured loans with a first lien on collateral, including “unitranche” loans, which are loans that combine the characteristics of both first lien and second lien debt of U.S. middle-market companies. The Company expects to provide investors with access to a portfolio of investments in the equity or debt of private U.S. companies or public companies with less than $250 million in market capitalization.

The Company is externally managed by Andalusian Credit Partners, LLC (“ACP,” in such capacity, the “Adviser”), a Delaware limited liability company that is registered with the U.S. Securities and Exchange Commission (the “SEC”) as an investment adviser under the Investment Advisers Act of 1940, as amended (the “Advisers Act”). ACP also serves as the Company’s administrator (in such capacity, the “Administrator”) pursuant to an administration agreement (the “Administration Agreement”).

The Company is conducting, on a continuous basis, a private offering (the “Private Offering”) of its limited liability company interests, par value $0.001 per share (“Shares”), to accredited investors, as defined in Regulation D under the Securities Act of 1933, as amended (the “Securities Act”), in reliance on exemptions from the registration requirements of the Securities Act. Shares will be offered for subscription continuously throughout an initial closing period and may be offered from time to time thereafter pursuant to the terms set forth in the Company’s confidential private placement memorandum, as may be amended, amended and restated, and/or supplemented from time to time (the “Memorandum”). Each investor in the Private Offering will make a capital commitment (a “Capital Commitment”) to purchase Shares of the Company pursuant to a subscription agreement entered into with the Company (the “Subscription Agreement”).

Note 2. Summary of Significant Accounting Policies

Basis of Presentation

The accompanying financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The Company is an investment company and, therefore, applies the specialized accounting and reporting guidance in Accounting Standards Codification (“ASC”) Topic 946, Financial Services — Investment Companies. The functional currency of the Company is the U.S. Dollar, and all transactions were in U.S. Dollars. Certain items have been reclassified in prior years to conform with the current period presentation.

Use of Estimates

The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Changes in the economic and regulatory environment, financial markets, the credit worthiness of our portfolio companies, other macro-economic developments (for example, global pandemics, natural disasters, terrorism, international conflicts and war), and any other parameters used in determining these estimates and assumptions could cause actual results to differ from these estimates and assumptions, and such differences could be material.

9

Table of Contents

Investments at Fair Value

Loan originations are recorded on the date of a binding commitment, which is generally the funding date. Investment transactions purchased through a secondary market are recorded on the trade date. Realized gains or losses are measured by the difference between the net proceeds from the repayment or sale and the amortized cost basis of the investment using the specific identification method without regard to unrealized appreciation or depreciation previously recognized, and includes investments charged off during the period, net of recoveries. Net change in unrealized appreciation or depreciation on investments reflects the net change in the fair value of investments, including the reversal of previously recorded unrealized appreciation or depreciation when gains or losses are realized. Fair value and amortized cost on positions with unfunded commitments can result in negative investment balances when unamortized discounts or fees are greater than the principal amount outstanding on the loan.

Fair Value Measurements

The Company applies fair value accounting in accordance with the terms of ASC 820, Fair Value Measurements (“ASC 820”), as amended, which establishes a framework for measuring fair value in accordance with U.S. GAAP and required disclosures of fair value measurements. ASC 820 determines fair value to be the price that would be received for an investment in a current sale, which assumes an orderly transaction between market participants on the measurement date. Market participants are defined as buyers and sellers in the principal or most advantageous market (which may be a hypothetical market) that are independent, knowledgeable, and willing and able to transact. In accordance with ASC 820, the Company considers its principal market to be the market that has the greatest volume and level of activity. ASC 820 specifies a fair value hierarchy that prioritizes and ranks the level of observability of inputs used in determination of fair value. In accordance with ASC 820, these levels are summarized below:

Level 1—Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.
Level 2—Valuations based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.
Level 3—Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment’s level within the fair value measurement. The assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment.

The Adviser, as the valuation designee of the board of managers (the “Board”), pursuant to Rule 2a-5 under the 1940 Act, determines in good faith the fair value of the Company’s investment portfolio for which market quotations are not readily available. The Adviser applies a valuation policy approved by the Board that is consistent with ASC 820 (“Valuation Policy”). In accordance with the Valuation Policy, the Adviser evaluates the source of the inputs, including any markets in which the Company’s investments are trading (or any markets in which securities with similar attributes are trading), in determining fair value. When an investment is valued based on prices provided by reputable dealers or pricing services (that is, broker quotes), the Adviser subjects those prices to various criteria in making the determination as to whether a particular investment would qualify for treatment as a Level 1, Level 2 or Level 3 investment.

Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Additionally, the fair value of such investments may differ significantly from the values that would have been used had a ready market existed for such investments and may differ materially from the values that may ultimately be realized. Further, such investments are generally less liquid than publicly traded securities and may be subject to contractual and other restrictions on resale. If the Company were required to liquidate a portfolio investment in a forced or liquidation sale, it could realize amounts that are different from the amounts presented and such differences could be material.

In addition, changes in the market environment and other events that may occur over the life of the investments may cause the gains or losses ultimately realized on these investments to be different than the unrealized gains or losses reflected herein.

10

Table of Contents

Cash and Cash Equivalents

Cash and cash equivalents may consist of demand deposits and highly liquid investments (e.g., money market funds, U.S. Treasury notes, and similar type instruments) with original maturities of three months or less. Cash and cash equivalents are categorized as Level 1 of the fair value hierarchy. The Company deposits its cash and cash equivalents with highly rated banking corporations and, at times, cash deposits may exceed the insured limits under applicable law.

Income Recognition

Interest income is recorded on the accrual basis and includes accretion or amortization of discounts or premiums. Discounts and premiums to par value on securities purchased are capitalized into the cost basis and accreted or amortized into interest income over the contractual life of the respective security using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion or amortization of discounts or premiums, if any.

Certain investments may have contractual payment-in-kind (“PIK”) interest or dividends. PIK interest represents accrued interest that is added to the principal amount of the investment on the respective interest payment dates rather than being paid in cash and generally becomes due at maturity. PIK dividends represent accrued dividends that are added to the shares held of the equity investment on the respective dividend payment dates rather than being paid in cash and generally becomes due at a certain trigger date. For the three months ended March 31, 2025 and 2024, the Company did not hold any investments that have contractual PIK interest or PIK dividends.

Other income may include income such as consent, waiver, amendment, unused, underwriting, arranger and prepayment fees associated with the Company’s investment activities as well as any fees for managerial assistance services rendered by the Company to the portfolio companies. Such fees are recognized as income when earned or the services are rendered.

Debt investments are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected in full. When a debt investment is placed on non-accrual status, the Company ceases to recognize interest income until the portfolio company has paid all principal and interest due or demonstrated the ability to repay its current and future contractual obligations to the Company. The Company may determine to continue to accrue interest on a loan where the investment has sufficient collateral value to collect all of the contractual amount due and is in the process of collection. Interest collected on non-accrual investments are generally applied to principal.

Dividend income on preferred equity securities is recorded on the accrual basis to the extent that such amounts are payable by the portfolio company and are expected to be collected. Dividend income on common equity securities is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly traded portfolio companies.

Organizational and Offering Expenses

Organizational expenses to establish the Company are expensed as incurred. These expenses consist primarily of legal fees and other costs of organizing the Company.

Offering expenses in connection with the offering of Shares are capitalized as a deferred charge and are amortized over a twelve-month period beginning with the later of either the Initial Closing Date or from incurrence. These costs consist primarily of legal and other fees incurred in connection with the Company’s Private Offering of its Shares.

In accordance with the Company's Memorandum, the Company will pay all initial organizational and offering expenses associated with the Private Offering of its Shares up to a maximum amount of 1.50% of aggregate Capital Commitments to the Company over the initial four-year period following the Initial Closing Date (the “Cap”). The Adviser will pay all organizational and offering expenses in excess of the Cap. Since inception through March 31, 2025, the Company has incurred $2,238,269 of organizational and offering expenses. For the three months ended March 31, 2025, the Company did not incur any organizational and offering expenses. For the three months ended March 31, 2024 the Company incurred $319,799 of organizational and offering expenses.

Deferred Financing Costs

Deferred financing costs are fees and other direct incremental costs incurred by the Company related to the closing or amendments of a debt borrowing. These costs are capitalized and amortized over the life of the related debt borrowing using the effective yield method or the straight-line method, which closely approximates the effective yield method. Deferred financing costs are generally presented as a reduction to the associated liability balance on the Statements of Assets and Liabilities, except for deferred financing costs associated with line-of-credit arrangements which are included within Prepaid expenses and other assets as permitted under GAAP.

11

Table of Contents

Expenses

Expenses are accrued in the period to which they are incurred. The Company will generally bear the following expenses, including but not limited to legal, tax, auditing, compliance, consulting and other professional expenses, the Management Fee and Incentive Compensation (each as defined below), professional liability insurance and research and market data expenses. Generally, research and market data expenses will be allocated among the Company and other funds or accounts managed by the Adviser on a pro rata basis. However, the Adviser has authority to negotiate arrangements with other funds and accounts pursuant to which those funds and accounts will not bear such expenses, despite benefiting, directly or indirectly, from the applicable products and services by participating in investments that have been analyzed with the help of those resources. In such instances, the Company and other funds and accounts that have not entered into such arrangements with the Adviser will bear more than their respective pro rata share of the applicable expenses. The Adviser currently manages one separate account client that does not bear investment related research and data costs pursuant to such an arrangement.

Income Taxes

The Company intends to elect to be treated for U.S. federal income tax purposes as a RIC under Subchapter M of the Code for the fiscal year ending December 31, 2025, and intends to make the required distributions to its shareholders to qualify and maintain its ability to be taxed as a RIC.

To qualify as a RIC, the Company must, among other things, meet certain source-of-income and asset diversification requirements as well as distribute each taxable year dividends for U.S. federal income tax purposes of an amount generally at least equal to 90% of the Company’s investment company taxable income (“ICTI”), as defined by the Code, each year. Depending on the level of ICTI earned in a tax year, the Company may choose to carry forward ICTI in excess of current year distributions into the next tax year. Any such carryover ICTI must be distributed before the end of that next tax year through a dividend declared prior to filing the final tax return related to the year which generated such ICTI. In addition, based on the excise distribution requirements, the Company is subject to a 4% nondeductible federal excise tax on undistributed income unless the Company distributes in a timely manner an amount at least equal to the sum of (1) 98% of its ordinary income for each calendar year, (2) 98.2% of capital gain net income (both long - term and short - term) for the one - year period ending October 31 in that calendar year and (3) any income realized, but not distributed, in the preceding year. For this purpose, however, any ordinary income or capital gain net income retained by the Company that is subject to corporate income tax is considered to have been distributed. The Company intends to timely distribute to our shareholders substantially all of our annual taxable income for each year, except that the Company may retain certain net capital gains for reinvestment and, depending upon the level of taxable income earned in a year, it may choose to carry forward taxable income for distribution in the following year and pay any applicable U.S. federal excise tax. So long as the Company qualifies for and maintains its tax treatment as a RIC, it generally will not be subject to corporate - level U.S. federal income taxes on any ordinary income or capital gains distributed to shareholders as dividends. Therefore, no provision for federal income taxes is recorded in the financial statements of the Company.

For periods prior to the effectiveness of our RIC election, the Company was subject to taxation as a corporation. There are no outstanding tax liabilities associated with such prior periods.

The Company evaluates tax positions taken or expected to be taken in the course of preparing its financial statements, to determine whether the tax positions are “more-likely-than-not” to be sustained by the applicable tax authority. Tax positions not deemed to meet the “more-likely-than-not” threshold are reserved and recorded as a tax benefit or expense in the current period. All penalties and interest associated with income taxes, as applicable, are included in income tax expense. Conclusions regarding tax positions are subject to review and may be adjusted at a later date based on factors including, but not limited to, on-going analyses of tax laws, regulations and interpretations thereof. The Company recognizes accrued interest and penalties, as applicable, related to unrecognized tax positions in the provision for income taxes. If recognized, the entire amount of unrecognized tax positions would be recorded as a reduction in the provision for income taxes. As of March 31, 2025 and December 31, 2024, there were no uncertain tax positions.  Furthermore, the Company is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will change significantly in the next 12 months.

Segment Reporting

The Company has determined that it has a single operating segment in accordance with Topic 280, Segment Reporting (“ASC 280”). As a result, the Company’s segment accounting policies are the same as described herein and the Company does not have any intra-segment sales and transfers of assets.

12

Table of Contents

The Company operates through a single operating and reporting segment with an investment objective to generate current income and capital appreciation by investing primarily in senior secured loans. The chief operating decision maker (“CODM”) is the management committee of the Adviser. The CODM uses our net investment income (loss) and net increase (decrease) in net assets resulting from operations as reported in the Statements of Operations to assess the Company’s performance and when allocating resources. Net Investment Income is comprised of total investment income (loss) and total net operating expenses, which are considered the key segment measures of profit or loss received by the CODM. As the Company’s operations comprise of a single reporting segment, the segment assets are reflected on the accompanying statements of assets and liabilities as “total assets” and the significant segment expenses are listed on the accompanying statements of operations.

Recent Accounting Pronouncements

In December 2023, the FASB issued ASU 2023-09, Income Taxes—Improvements to Income Tax Disclosures. This guidance enhances the transparency and decision usefulness of income tax disclosures. The effective date for the amendments in ASU 2023-09 are for fiscal years beginning after December 15, 2024. The Company is currently assessing the impact of this guidance, however, the Company does not expect a material impact on its financial statements.

In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (“ASU 2024-03”), which requires disaggregated disclosure of certain costs and expenses, including purchases of inventory, employee compensation, depreciation, amortization and depletion, within relevant income statement captions. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods beginning with the first quarter ended March 31, 2028. Early adoption and retrospective application is permitted. The Company is currently assessing the impact of this guidance, however, the Company does not expect a material impact on its financial statements.

Note 3. Related Party Transactions

Advisory Agreement

Subject to the overall supervision of the Board and in accordance with the 1940 Act, the Adviser manages the Company’s day-to-day operations and provides investment advisory services to the Company.

Under the Advisory Agreement, the Company will pay the Adviser fees for investment management services consisting of a base management fee (the “Management Fee”) and an incentive fee (the “Incentive Compensation”).

Management Fee

Pursuant to the Advisory Agreement, the Company will pay to the Adviser a Management Fee, payable quarterly in arrears at a rate of 1.50% per annum of the sum of (1) the Members’ total unfunded Capital Commitments and (2) the Company’s total assets (excluding cash or cash equivalents but including assets purchased with borrowed amounts) as of the end of the most recently completed calendar quarter. In the event the Company engages in a listing on a nationally recognized stock exchange (“Exchange Listing”), the Company will pay to the Adviser an annual Management Fee, payable quarterly in arrears at a rate of 1.75% per annum of the Company’s total assets (excluding cash or cash equivalents but including assets purchased with borrowed amounts) as of the end of the most recently completed calendar quarter. The Adviser contractually agreed to waive 0.25% of the Management Fee for a one-year period beginning on the Company’s Initial Closing Date and ended November 14, 2024.

For the three months ended March 31, 2025 and 2024, the Company incurred Management Fees of $1,547,910 and $1,204,753, net of the Management Fee waiver of none and $240,951, each respectively. As of March 31, 2025 and December 31, 2024, the Company had Management Fees payable of $1,547,910 and $1,520,781, respectively.

Incentive Compensation

Incentive Compensation is payable by the Company to the Adviser and consists of two components that are independent of each other, with the result that one component may be payable even if the other is not. A portion of the incentive fee is based on a percentage of the Company’s income (an “Income Incentive Fee”) and a portion is based on a percentage of the Company’s capital gains (the “Capital Gains Incentive Fee”).

13

Table of Contents

Income Incentive Fee

The Income Incentive Fee is payable quarterly in arrears and is calculated by comparing “Pre-incentive fee net investment income” to a “Hurdle Amount”, which is equal to the product of (i) the “hurdle rate” of 1.25% per quarter (5% annualized) and (ii) the Company’s net assets (defined as total assets less indebtedness and before taking into account any incentive fees payable during the period) at the end of the immediately preceding calendar quarter.

“Pre-incentive fee net investment income” means interest income, dividend income and any other income (including any other fees such as commitment, origination, structuring, diligence and consulting fees or other fees that we receive from portfolio companies but excluding fees for providing managerial assistance) accrued during the calendar quarter, minus operating expenses for the quarter (including the Management Fee, any expenses payable under the Administration Agreement, and any interest expense and dividends paid on any outstanding preferred stock, but excluding the incentive fee). Pre-incentive fee net investment income includes, in the case of investments with a deferred interest feature such as market discount, original issue discount, debt instruments with PIK interest, preferred stock with PIK dividends and zero-coupon securities, accrued income that we have not yet received in cash.

Prior to an Exchange Listing, the Company will pay the Income Incentive Fee in each calendar quarter as follows:

No Income Incentive Fee in any calendar quarter in which the Company’s pre-incentive fee net investment income does not exceed the Hurdle Amount;
100% of the Company’s pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income, if any, that exceeds the Hurdle Amount but is less than or equal to an amount (the “Pre-Exchange Listing Catch-Up Amount”) determined on a quarterly basis by multiplying 1.4705% (5.882% annualized) by the Company’s NAV at the beginning of each applicable calendar quarter. The Pre-Exchange Listing Catch-Up Amount is intended to provide the Adviser with an incentive fee of 15% on all of the Company’s pre-incentive fee net investment income when the Company’s pre-incentive fee net investment income reaches the Pre-Exchange Listing Catch-Up Amount in any calendar quarter; and
For any calendar quarter in which the Company’s pre-incentive fee net investment income exceeds the Pre-Exchange Listing Catch-Up Amount, the Income Incentive Fee shall equal 15% of the amount of the Company’s pre-incentive fee net investment income for the calendar quarter.

Prior to an Exchange Listing, the Income Incentive Fee is subject to a cap (the “Pre-Exchange Listing Incentive Fee Cap”). The Pre-Exchange Listing Incentive Fee Cap in respect of any quarter is an amount equal to 15% of the Pre-Incentive Fee Net Return during the relevant quarter.

“Pre-Incentive Fee Net Return” during the relevant quarter means (x) pre-incentive fee net Investment income in respect of the quarter less (y) any Net Capital Loss, if any. “Net Capital Loss” in respect of a particular quarter means the difference, if positive, between (i) aggregate capital losses, whether realized or unrealized, in respect of such quarter and (ii) aggregate capital gains, whether realized or unrealized, in respect of such quarter.

If, in any calendar quarter, the Pre-Exchange Listing Incentive Fee Cap is zero or a negative value, the Company shall pay no Income Incentive Fee to the Adviser in respect of that quarter. If, in any calendar quarter, the Pre-Exchange Listing Incentive Fee Cap is a positive value but is less than the Income Incentive Fee amount, the Company shall pay the Adviser the Pre-Exchange Listing Incentive Fee Cap in respect of such quarter. If, in any calendar quarter, the Incentive Fee Cap is equal to or greater than the Income Incentive Fee, the Company shall pay the Adviser the Income Incentive Fee in respect of such quarter.

On and after the occurrence of an Exchange Listing, the Company will pay the Income Incentive Fee in each calendar quarter as follows:

No Income Incentive Fee in any calendar quarter in which the Company’s pre-incentive fee net investment income does not exceed the Hurdle Amount;
100% of the Company’s pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income, if any, that exceeds the Hurdle Amount but is less than or equal to an amount (the “Post-Exchange Listing Catch-Up Amount”) determined on a quarterly basis by multiplying 1.5625% (6.25% annualized) by the Company’s NAV at the beginning of each applicable calendar quarter. The Post - Exchange Listing Catch - Up Amount is intended to provide the Adviser with an incentive fee of 20% on all of the Company's pre - incentive fee net investment income when the Company's pre - incentive fee net investment income reaches the Post - Exchange Listing Catch - Up Amount in any calendar quarter; and

14

Table of Contents

For any calendar quarter in which the Company's pre - incentive fee net investment income exceeds the Post - Exchange Listing Catch - Up Amount, the Income Incentive Fee shall equal 20% of the amount of the Company’s pre-incentive fee net investment income for the calendar quarter.

Subsequent to an Exchange Listing, the Income Incentive Fee is subject to a cap (the "Post - Exchange Listing Incentive Fee Cap"). The Post - Exchange Listing Incentive Fee Cap in respect of any quarter is an amount equal to 20% of the Pre - Incentive Fee Net Return during the relevant quarter.

If, in any calendar quarter, the Post-Exchange Listing Incentive Fee Cap is zero or a negative value, the Company shall pay no Income Incentive Fee to the Adviser in respect of that quarter. If, in any calendar quarter, the Incentive Fee Cap is a positive value but is less than the Income Incentive Fee amount, the Company shall pay the Adviser the Post-Exchange Listing Incentive Fee Cap in respect of such quarter. If, in any calendar quarter, the Incentive Fee Cap is equal to or greater than the Income Incentive Fee, the Company shall pay the Adviser the Income Incentive Fee in respect of such quarter.

These calculations will be appropriately pro-rated for any period of less than three months and adjusted for any share issuances or repurchases by the Company during the current quarter. The Company does not currently intend to institute a share repurchase program and share repurchases will be effected only in extremely limited circumstances in accordance with applicable law. If the Exchange Listing occurs on a date other than the first day of a calendar quarter, the Income Incentive Fee shall be calculated for such calendar quarter at a weighted rate calculated based on the fee rates applicable before and after an Exchange Listing based on the number of days in such calendar quarter before and after an Exchange Listing.

For the three months ended March 31, 2025 and 2024, the Company did not incur any Income Incentive Fees.

Capital Gains Incentive Fee

The second component of the Incentive Compensation, the Capital Gains Incentive Fee, which is payable at the end of each calendar year in arrears and equals (i) 15% of the Company’s realized capital gains as of the end of the fiscal year prior to an initial public offering, an Exchange Listing, or (a) the sale of all or substantially all of the Company’s assets to, or other liquidity event with, another entity or (b) a transaction or series of transactions, including by way of merger, consolidation, recapitalization, reorganization, or sale of Shares, in each case for consideration of either cash and/or publicly listed securities of the acquirer (each, a "Liquidity Event") and (ii) 20% of the Company's realized capital gains as of the end of the fiscal year after a Liquidity Event.

In determining the Capital Gains Incentive Fee payable to the Adviser, we calculate the cumulative aggregate realized capital gains and cumulative aggregate realized capital losses since the Company’s inception, and the aggregate unrealized capital depreciation as of the date of the calculation, as applicable, with respect to each of the investments in the Company’s portfolio. For this purpose, cumulative aggregate realized capital gains, if any, equals the sum of the differences between the net sales price of each investment, when sold, and the original cost of such investment since the Company's inception. Cumulative aggregate realized capital losses equals the sum of the amounts by which the net sales price of each investment, when sold, is less than the original cost of such investment since the Company's inception. Aggregate unrealized capital depreciation equals the sum of the difference, if negative, between the valuation of each investment as of the applicable calculation date and the original cost of such investment. At the end of the applicable year, the amount of capital gains that serves as the basis for the Company’s calculation of the Capital Gains Incentive Fee equals the cumulative aggregate realized capital gains less cumulative aggregate realized capital losses, less aggregate unrealized capital depreciation, with respect to the Company’s portfolio of investments. If this number is positive at the end of such year, then the Capital Gains Incentive Fee for such year will equal 15% before an Exchange Listing or 20% after an Exchange Listing, as applicable, of such amount, less the aggregate amount of any Capital Gains Incentive Fees paid in respect of the Company's portfolio in all prior years.

If an Exchange Listing occurs on a date other than the first day of a fiscal year, a Capital Gains Incentive Fee shall be calculated as of the day before the Exchange Listing, with such Capital Gains Incentive Fee paid to the Adviser following the end of the fiscal year in which the Exchange Listing occurred. For the avoidance of doubt, such Capital Gains Incentive Fee shall be equal to 15% of the Company's realized capital gains on a cumulative basis from inception through the day before the Exchange Listing, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid Capital Gains Incentive Fees. Following an Exchange Listing, solely for the purposes of calculating the Capital Gains Incentive Fee, the Company will be deemed to have previously paid Capital Gains Incentive Fees prior to an Exchange Listing equal to the product obtained by multiplying (a) the actual aggregate amount of previously paid Capital Gains Incentive Fees for all periods prior to an Exchange Listing by (b) the percentage obtained by dividing (x) 20% by (y) 15%. In the event that the Advisory Agreement shall terminate as of a date that is not a fiscal year end, the termination date shall be treated as though it were a fiscal year end for purposes of calculating and paying a Capital Gains Incentive Fee.

15

Table of Contents

For the three months ended March 31, 2025 and 2024, the Company did not incur any Capital Gains Incentive Fees.

Administration Agreement

Under the Administration Agreement, the Administrator furnishes the Company with office facilities and equipment and will provide the Company with clerical, bookkeeping, recordkeeping and other administrative services. The Administrator also performs, or oversees the performance of, the Company’s required administrative services, which include being responsible for the financial and other records that the Company is required to maintain and preparing reports to its investors and reports and other materials filed with the SEC. In addition, the Administrator assists the Company in determining and publishing its NAV, oversees the preparation and filing of its tax returns and the printing and dissemination of reports and other materials to its investors, and generally oversees the payment of its expenses and the performance of administrative and professional services rendered to the Company by others. Under the Administration Agreement, the Administrator also provides managerial assistance on the Company’s behalf to those portfolio companies that have accepted the Company’s offer to provide such assistance.

Under the terms of the Administration Agreement, the Administrator may retain a sub-administrator to provide certain administrative services to the Company. The Administrator has retained SS&C Technologies, Inc. as a sub-administrator to perform any or all of its obligations under the Administration Agreement.

The Administrator is authorized to incur and pay, in the name and on behalf of the Company, all expenses which it deems necessary or advisable. The Company will pay to the Administrator an annual administration fee of 0.25% on the Company’s total Capital Commitments, payable quarterly in arrears, for services and facilities provided under the Administration Agreement (the “Administration Fee”). For purposes of the Administration Fee, total Capital Commitments equals the sum of the investors’ funded Capital Commitments and unfunded Capital Commitments at the end of each fiscal quarter.

For the three months ended March 31, 2025 and 2024, the Company incurred Administration Fees of $317,443 and $242,003, respectively. As of March 31, 2025 and December 31, 2024, the Company recorded Administration Fees payable of $317,443 and $316,040, respectively.

Note 4. Investments

The following table presents the composition of the Company’s investment portfolio at cost and fair value as of March 31, 2025 and December 31, 2024:

    

March 31, 2025

    

December 31, 2024

    

    

Net Unrealized

    

    

Net Unrealized

Appreciation

Appreciation

Amortized Cost (1)

Fair Value

(Depreciation)

Amortized Cost (1)

Fair Value

(Depreciation)

First Lien Term Loans

$

111,786,779

$

111,635,774

$

(151,005)

$

91,004,288

$

91,188,202

    

$

183,914

Total

$

111,786,779

$

111,635,774

$

(151,005)

$

91,004,288

$

91,188,202

    

$

183,914

(1)

The amortized cost represents the original cost adjusted for the amortization of discounts or premiums, as applicable, on debt investments using the effective interest method.

The geographic composition of investments based on fair value as of March 31, 2025 and December 31, 2024 was as follows:

    

March 31, 2025

December 31, 2024

United States

 

100.0

%

100.0

%

Total

 

100.0

%

100.0

%

16

Table of Contents

The industry composition of investments based on fair value as of March 31, 2025 and December 31, 2024 was as follows:

    

March 31, 2025

December 31, 2024

 

Services: Business

 

23.7

%

36.9

%

Healthcare & Pharmaceuticals

20.0

%

24.7

%

Transportation: Cargo

14.8

%

%

Retail

9.6

%

%

Capital Equipment

9.4

%

11.6

%

FIRE: Insurance

8.1

%

9.9

%

FIRE: Finance

5.5

%

6.2

%

High Tech Industries

4.9

%

5.7

%

Media: Diversified & Production

4.0

%

5.0

%

Total

 

100.0

%

100.0

%

Note 5. Fair Value Measurements

The following tables summarize the Company’s investments, measured at fair value by the fair value hierarchy levels, as of March 31, 2025 and December 31, 2024.

    

As of March 31, 2025

Assets

Level 1

    

Level 2

    

Level 3

    

Total

First Lien Term Loans

$

$

$

111,635,774

$

111,635,774

Cash Equivalents

90,386,298

90,386,298

Total

$

90,386,298

$

$

111,635,774

$

202,022,072

As of December 31, 2024

Assets

    

Level 1

    

Level 2

    

Level 3

    

Total

First Lien Term Loans

 

$

 

$

 

$

91,188,202

 

$

91,188,202

Cash Equivalents

58,868,006

58,868,006

Total

 

$

58,868,006

 

$

 

$

91,188,202

 

$

150,056,208

Transfers between levels, if any, are recognized at the beginning of the quarter in which the transfers occur. For the three months ended March 31, 2025 and 2024, there were no transfers between levels.

The following tables present a summary of changes in fair value of Level 3 assets by investment type for the three months ended March 31, 2025 and 2024:

    

First Lien

    

Term Loans

Total

Fair Value as of December 31, 2024

$

91,188,202

$

91,188,202

Purchases

 

28,045,502

 

28,045,502

Accretion of discount and fees (amortization of premium), net

 

98,637

 

98,637

Proceeds from principal repayments

 

(7,361,648)

 

(7,361,648)

Net change in unrealized appreciation (depreciation) from non-controlled non-affiliated investments

(334,919)

(334,919)

Balance as of March 31, 2025

$

111,635,774

$

111,635,774

Net change in unrealized appreciation (depreciation) on Level 3 investments still held as of March 31, 2025

$

(329,874)

$

(329,874)

17

Table of Contents

    

First Lien Term

    

 Loans

Total

Fair Value as of December 31, 2023

$

$

Purchases

 

19,820,356

 

19,820,356

Accretion of discount and fees (amortization of premium), net

 

10,510

 

10,510

Proceeds from principal repayments

 

(50,591)

 

(50,591)

Balance as of March 31, 2024

$

19,780,275

$

19,780,275

Net change in unrealized appreciation (depreciation) on Level 3 investments still held as of March 31, 2024

$

$

The Company generally uses the following framework when determining the fair value of investments that are categorized as Level 3:

The fair value of the Company’s investment portfolio for which market quotations are not readily available is determined by the Adviser’s valuation committee, subject to oversight by the Board, consistent with the Valuation Policy. In connection with that determination, investment valuations will be prepared using ranges of valuations obtained from independent valuation firms, and/or proprietary models depending on the materiality of the investments, the availability of information on the Company’s investments and the type of investment being valued, all in accordance with the Valuation Policy.

Determination of fair value involves subjective judgments and estimates. As part of the valuation process, the factors that may be taken into account in determining the fair value of the Company’s investments, include, as relevant: the estimated enterprise value of a portfolio company (i.e., the total fair value of the portfolio company’s debt and equity), the nature and realizable value of any collateral, the portfolio company’s ability to make payments based on its earnings and cash flow, the markets in which the portfolio company does business, a comparison of the portfolio company’s securities to any similar publicly traded securities, and overall changes in the interest rate environment and the credit markets that may affect the price at which similar investments may be made in the future. When an external event such as a purchase transaction, public offering or subsequent equity sale occurs, the Adviser’s valuation committee will consider whether the pricing indicated by the external event corroborates its valuation.

Investments in debt securities are initially evaluated to determine whether the enterprise value of the portfolio company is greater than the applicable debt. The enterprise value of the portfolio company is estimated using a market approach and an income approach. The market approach utilizes market value (EBITDA) multiples of publicly traded comparable companies and available precedent sales transactions of comparable companies. The Adviser carefully considers numerous factors when selecting the appropriate companies whose multiples are used to value the Company’s portfolio companies. These factors include, but are not limited to, the type of organization, similarity to the business being valued, relevant risk factors, as well as size, profitability and growth expectations. The income approach typically uses a discounted cash flow analysis of the portfolio company.

Investments in debt securities that do not have sufficient coverage through the enterprise value analysis are valued based on an expected probability of default and discount recovery analysis.

Investments in debt securities with sufficient coverage through the enterprise value analysis are generally valued using a discounted cash flow “yield analysis” of the underlying security. Projected cash flows in the discounted cash flow typically represent the relevant security’s contractual interest, fees and principal payments plus the assumption of full principal recovery at the security’s expected maturity date.

The following tables summarize the quantitative information related to the significant unobservable inputs for Level 3 instruments which are carried at fair value as of March 31, 2025 and December 31, 2024:

    

    

  Valuation

    

  

  

 

Fair Value as of

Techniques/

Unobservable

Range

Weighted

 

Investment Type

March 31, 2025

Methodologies

Input

    

Low

    

High

    

Average (1)

 

First Lien Term Loans

$

27,223,932

 

Recent Transaction

 

Transaction Price

 

98.00

%  

99.25

%  

98.76

%  

 

84,411,842

 

Income - Yield Analysis

 

Discount Rate

 

8.30

%  

13.55

%  

10.15

%

Total

$

111,635,774

 

  

 

  

 

  

 

  

 

  

(1)The weighted average is calculated based on the fair value of each investment.

18

Table of Contents

Valuation

    

Fair Value as of

    

 Techniques/

    

Unobservable

    

Range

    

Weighted

 

Investment Type

December 31, 2024

Methodologies

Input

Low

High

Average (1)

 

 

First Lien Term Loans

$

14,189,463

 

Recent Transaction

 

Transaction Price

 

99.00

%  

99.50

%  

99.50

%

 

76,998,739

 

Income - Yield Analysis

 

Discount Rate

8.17

%  

12.94

%  

10.19

%

Total

$

91,188,202

 

  

 

  

 

  

 

  

 

  

(1)The weighted average is calculated based on the fair value of each investment.

The significant unobservable inputs used in the fair value measurement of the Company’s investments in first lien term loans are discount rates and transaction prices. Significant increases in discount rates in isolation would result in a significantly lower fair value measurement.

The carrying value of other financial assets and liabilities approximates their fair value based on the short-term nature of these items.

Note 6. Borrowings

The Company, pursuant to shareholder approval received in August 2023, is permitted to borrow amounts such that its asset coverage ratio, as defined in the 1940 Act, is at least 150% after such borrowing (if certain requirements are met). The Company has entered into a $75,000,000 senior secured revolving credit facility with CIBC Bank USA (the “CIBC Credit Facility”). The CIBC Credit Facility, by and among the Company, as borrower, CIBC Bank USA, as Administrative Agent and letter of credit issuer, and the financial institutions party thereto. On December 13, 2024 the Company entered into a first amendment to the CIBC Credit Facility which amended certain provisions of the CIBC Credit Facility to, among other things, extend the Stated Maturity Date from February 12, 2025, to December 12, 2025, which may further be extended for an additional period of up to one year subject to consent of the Administrative Agent and extending lenders. The Company has an accordion provision to request, at one or more times, that existing and/or new lenders, at their election, provide up to $175,000,000. The Company’s obligations under the CIBC Credit Facility are secured by the Company’s ability to draw capital from its investors, the Capital Commitments and capital contributions of such investors, the bank accounts into which such capital contributions are funded and any other assets.

Borrowings under the CIBC Credit Facility are subject to compliance with a borrowing base test. Amounts drawn under the CIBC Credit Facility in U.S. dollars will bear interest at either term 1 Month SOFR plus 2.75%, or the base rate plus 1.75%. The Company is also subject to a non-use fee of 0.35% per annum, payable quarterly in arrears based on the average daily unused amount of the available commitments.

In connection with the CIBC Credit Facility, the Company has made certain representations and warranties and must comply with various customary covenants and reporting requirements. The CIBC Credit Facility contains events of default customary for facilities of this type. Upon the occurrence of an event of default, the Administrative Agent, at the request of the required lenders, may terminate the commitments and declare the outstanding advances and all other obligations under the CIBC Credit Facility immediately due and payable. The Company was in compliance with all covenants and other requirements under the CIBC Credit Facility as of March 31, 2025.

As of March 31, 2025 and December 31, 2024, the unused portion and amount available to draw under the CIBC Credit Facility were $75,000,000.

19

Table of Contents

For the three months ended March 31, 2025 and 2024, the components of interest expense and other financing costs were as follows:

    

Three months

    

Three months

 

ended

ended

March 31, 2025

 

March 31, 2024

 

Interest expense

$

$

10,795

Unused commitment fee

 

65,625

 

35,267

Amortization of deferred financing costs

 

81,874

 

70,778

Total interest expense and other financing costs

147,499

116,840

Average principal debt outstanding

$

$

521,978

Average interest rate

8.32

%

As of March 31, 2025 and December 31, 2024, the components of interest and other financing costs payable were as follows:

March 31, 2025

December 31, 2024

Interest expense payable

$

$

Unused commitment fee payable

 

61,979

 

62,708

Total interest expense and credit facility fees payable

$

61,979

$

62,708

As of March 31, 2025, the unamortized balance of financing costs of $232,885 is deferred and included in prepaid expenses and other assets in the accompanying Statements of Assets and Liabilities.

Note 7. Commitments and Contingencies

The Company may enter into investment commitments through executed credit agreements or commitment letters. In many circumstances for executed commitment letters, borrower acceptance and final terms are subject to transaction-related contingencies. As of March 31, 2025, the Company believed that it had adequate financial resources to satisfy its unfunded commitments.

As of March 31, 2025, the Company had the following unfunded commitments:

Par as of

Company

    

March 31, 2025

    

December 31, 2024

A. Stucki Company

$

6,069,197

$

Allworth Financial Group, L.P.

5,078,390

5,547,836

Allworth Financial Group, L.P.

261,268

261,268

Komline-Sanderson Group, Inc.

5,218,858

5,218,858

Komline-Sanderson Group, Inc.

2,124,366

2,124,366

NPM Franchising, LLC

1,820,035

OneZero

608,958

918,686

OneZero

656,204

656,204

Pediatric Home Respiratory Services, LLC

2,730,052

2,730,052

Pediatric Home Respiratory Services, LLC

1,274,025

1,274,025

StrategyCorps, LLC

2,274,436

2,274,436

StrategyCorps, LLC

1,080,357

1,137,218

Total (1)

$

29,196,146

$

22,142,949

(1) The Adviser’s determination of the fair value of the current investments in these portfolio companies includes an analysis of the fair value of any unfunded commitments.

From time to time, the Company may become a party to certain legal proceedings incidental to the normal course of its business. As of March 31, 2025 and December 31, 2024, the Company is not aware of any pending or threatened litigation. Additionally, in the ordinary course of its business, the Company enters into contracts or agreements that contain indemnification or warranties. Future events could occur that lead to the execution of these provisions against the Company. The Company believes that the likelihood of such an event is remote; however, the maximum potential exposure is unknown. No accrual has been made in the financial statements as of March 31, 2025 and December 31, 2024 for any such exposure.

20

Table of Contents

Note 8. Net Assets

Unregistered Sales of Equity Securities

As of March 31, 2025, the Company had the authority to issue an unlimited number of Shares at $0.001 par value per share. The following table summarizes the Company’s share issuances since inception through March 31, 2025.

Shares

Proceeds

Average Issuance

Share Issuance Date

    

Issued

    

Received

    

Price per Share

June 30, 2023

50

$

1,000

$

20.00

November 14, 2023

171,824

3,436,474

20.00

February 13, 2024

 

973,655

19,473,102

20.00

April 15, 2024

 

2,482,469

 

38,892,227

 

15.67

September 3, 2024

2,901,546

44,013,319

15.17

December 2, 2024

3,333,813

50,542,802

15.16

March 3, 2025

3,375,974

51,358,465

15.21

Total

 

13,239,331

$

207,717,389

$

15.69

The sales of the Shares were made pursuant to subscription agreements entered into by the Company with its investors. Under the terms of the subscription agreements, each investor is required to fund drawdowns to purchase Shares up to the amount of their respective Capital Commitments each time the Company delivers a drawdown notice with a minimum of 10 business days’ prior notice to the date on which payment will be due.

As of March 31, 2025 and December 31, 2024, the Company had 13,239,331 and 9,863,357 shares outstanding, respectively. As of March 31, 2025, the Company had $507,908,450 of capital commitments, of which $299,665,395 remained undrawn. As of December 31, 2024, the Company had $505,663,513 of capital commitments, of which $348,907,133 remained undrawn.

There were no dividends declared or reinvested from inception through March 31, 2025.

Share Repurchases

Prior to a Liquidity Event, and subject to market conditions and the Board’s commercially reasonable judgment, the Company may from time to time offer to repurchase Shares pursuant to written tenders by Members.

The Company does not currently intend to institute a share repurchase program and share repurchases will be effected only in extremely limited circumstances in accordance with applicable law. Any periodic repurchase offers are subject in part to our available cash and compliance with the BDC and RIC qualification and diversification rules promulgated under the 1940 Act and the Code, respectively.

During the three months ended March 31, 2025 and 2024, the Company did not repurchase any Shares.

Note 9. Earnings Per Share

The Company computes earnings per share in accordance with ASC 260. Basic and diluted earnings per share was calculated by dividing net increase / (decrease) in net assets resulting from operations by the weighted average number of shares outstanding for the period. The following table sets forth the computation of basic and diluted earnings per share for the three months ended March 31, 2025 and 2024:

    

Three months

    

Three months

ended

ended

March 31, 2025

March 31, 2024

Net increase (decrease) in net assets resulting from operations

$

387,399

$

(2,223,930)

Weighted average shares outstanding

10,951,171

664,051

Basic and diluted gain (loss) per share

$

0.04

$

(3.35)

21

Table of Contents

Note 10. Tax Matters

The Company intends to comply with the provisions of the Code applicable to RICs for the tax period ending December 31, 2025. So long as the Company maintains its tax treatment as a RIC, it generally will not be subject to corporate - level U.S. federal income taxes on any ordinary income or capital gains distributed to shareholders as dividends. As such, no taxes were accrued for the three months ended March 31, 2025.

For periods prior to the effectiveness of our RIC election, it is not anticipated that the Company will incur U.S. federal, state, and local taxes (other than nominal state and local taxes) as a corporation and consequently, no such taxes were accrued. For the three months ended March 31, 2024 and as of December 31, 2024, the Company was subject to taxation as a U.S. corporation. Total income tax (expense) benefit for the Company differs from the amount computed by applying the federal statutory income tax rate of 21% to net increase (decrease) in net assets from operations for the three months ended March 31, 2024, as follows:

    

March 31, 2024

Income tax benefit at federal statutory rate (21.0%)

$

467,026

State and local income tax benefit (estimated 11.7%, net of federal detriment)

 

260,654

Permanent book/tax differences

 

(104,640)

Valuation allowance

 

(623,040)

Total income tax (expense)/benefits

$

As of December, 31, 2024, the Company’s income tax provision consisted of the following:

    

December 31, 2024

Current tax (expense)/benefit:

  

Federal

$

State and Local

 

Total current tax (expense)/benefit

 

Deferred tax (expense)/benefit:

 

  

Federal

 

1,118,657

State and Local

 

624,340

Total

 

1,742,997

Valuation allowance

 

(1,742,997)

Total deferred tax (expense)/benefit

 

Total income tax (expense)/benefit

$

Deferred income taxes reflect the net tax effect of temporary differences between the carrying amount of assets and liabilities, including organizational expenses, for financial reporting and tax purposes. Components of the Company’s deferred tax assets and liabilities as of December 31, 2024 were as follows:

    

December 31, 2024

Deferred tax assets:

  

Net operating loss carryforward

$

1,454,652

Organizational costs

 

288,345

Total

 

1,742,997

Valuation allowance

 

(1,742,997)

Total deferred tax assets

Deferred tax liabilities:

 

  

Total deferred tax liabilities

 

Net deferred tax assets and liabilities

$

22

Table of Contents

As of December 31, 2024, the Company determined a valuation allowance was required. The Company’s assessment considered, among other matters, the nature, frequency and severity of current and cumulative losses, the duration of statutory carryforward periods and the associated risk that operating loss and capital loss carryforwards are limited or are likely to expire unused. Through the consideration of these factors, the Company has determined that it is more likely than not that the Company’s net deferred tax asset would not be realized. As a result, the Company recorded a full valuation allowance with respect to its deferred tax asset as of December 31, 2024.

From time to time, the Company may modify its estimates or assumptions regarding its deferred tax liability and/or asset balances and any applicable valuation allowance as new information becomes available. Modifications to the Company’s estimates or assumptions regarding its deferred tax liability and/or asset balances and any applicable valuation allowance, changes in generally accepted accounting principles or related guidance or interpretations thereof, limitations imposed on or expirations of the Company’s net operating losses and capital loss carryovers (if any) and changes in applicable tax law could result in increases or decreases in the Company’s NAV per share, which could be material.

As of December 31, 2024, the Company had a net operating loss carryforward for federal and state income tax purposes of $1,454,652. This net operating loss may be carried forward indefinitely but would not be useable to offset income in taxable years in which the Company qualifies as a RIC. As of December 31, 2024, the Company did not have any capital loss carryforward.

Note 11. Financial Highlights

The following table presents the schedule of financial highlights of the Company the three months ended March 31, 2025 and 2024:

    

Three months

 

Three months

 

ended

 

ended

 

    

March 31, 2025

    

March 31, 2024

Per share data: (1)

  

 

  

 

Net asset value at beginning of period

$

15.18

$

5.47

(2)

Net investment gain (loss)

 

0.07

 

(3.35)

Net change in unrealized appreciation (depreciation)

 

(0.03)

 

Net increase (decrease) in net assets resulting from operations

 

0.04

 

(3.35)

Issuance of Shares*

13.76

Distributions declared

Net asset value at end of period

$

15.22

$

15.88

Shares outstanding at end of period

 

13,239,331

 

1,145,529

Weighted average net assets

$

175,622,209

$

9,565,502

Weighted average shares outstanding

 

10,951,171

 

664,051

Total return based on net asset value (3)

 

0.26

%  

 

190.33

%

Supplemental Data/Ratio:

 

 

Net assets at end of period

$

201,495,141

$

18,190,088

Ratio of total expenses to average net assets (4)

 

6.01

%  

 

113.24

%

Ratio of net expenses after waivers to average net assets (4)

 

6.01

%  

 

103.11

%

Ratio of net investment income (loss) to average net assets (4)

1.67

%  

(93.51)

%

Portfolio turnover

 

10.34

%  

 

%

*

The per share impact of shares issued for the three months ended March 31, 2025 approximated less than $0.01 per share.

(1)The per share data was derived by using the weighted average shares outstanding during the applicable period, except for distributions declared, as applicable, which reflects the actual amount per share for the applicable period.
(2)Not meaningful given the timing and amount of the Company’s first drawdown.
(3)Calculated as the change in NAV per share during the respective periods, assuming dividends and distributions, if any, are reinvested in accordance with the Company’s distribution reinvestment plan.
(4)Annualized.

Note 12. Subsequent Events

The Company’s management has evaluated subsequent events through the date of issuance of the financial statements. There have been no subsequent events that occurred during such period that would require disclosure in, or would be required to be recognized in the financial statements.

23

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The information contained in this section should be read in conjunction with “ITEM 1. FINANCIAL STATEMENTS”. This discussion contains forward-looking statements, which relate to future events or the future performance or financial condition of Andalusian Credit Company, LLC (“ we,” “ us,” “ our,” or the “ Company”) and involves numerous risks and uncertainties, including, but not limited to, those described in our Form 10-K for the fiscal year ended in December 31, 2024 “ITEM 1A. RISK FACTORS”. Actual results could differ materially from those implied or expressed in any forward-looking statements.

Forward-Looking Statements

Some of the statements in this quarterly report on Form 10-Q constitute forward-looking statements, which relate to future events or our future performance or financial condition. The forward-looking statements contained in this quarterly report on Form 10-Q involve risks and uncertainties, including statements as to:

our current and future management structure;
our future operating results;
our business prospects and the prospects of our portfolio companies;
our ability to operate as a business development company (“BDC”);
the adequacy of our financing sources and working capital;
our informal relationships with third parties including sponsor parties in the middle-market;
the ability of our portfolio companies to achieve their objectives;
the occurrence and impact of macro-economic developments (for example, global pandemics, natural disasters, terrorism, international conflicts and war) on us and our portfolio companies;
the effect of investments that we expect to make and the competition for those investments;
actual and potential conflicts of interest with Andalusian Credit Partners, LLC (“ACP” or the “Adviser”), Andalusian Private Capital, LP, Andalusian Sports Advisor, LP, and their affiliates;
the timing of cash flows, if any, from the operations of our portfolio companies;
the dependence of our future success on the general economy and its impact on the industries in which we invest;
the ability of the Adviser to locate suitable investments for us and to monitor and administer our investments;
the ability of the Adviser or its affiliates to attract and retain highly talented professionals;
our ability to qualify and maintain our qualification as a regulated investment company, or RIC, under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”) and as a BDC;
our ability to access debt markets and equity markets;
our expected financings and investments;
the adequacy of our cash resources and working capital;
the timing of cash flows, if any, from the operations of our portfolio companies;
the timing, form and amount of any distributions;
the impact of fluctuations in interest rates on our business;
the valuation of any investments in portfolio companies, particularly those having no liquid trading market; and
our ability to recover unrealized depreciation on investments.

Words such as “may,” “will,” “should,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” “target,” “goals,” “plan,” “forecast,” “project,” other variations on these words or comparable terminology, or the negative of these words are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors,

24

Table of Contents

some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements.

You should not place undue reliance on these forward-looking statements. We have based the forward-looking statements included in this quarterly report on Form 10-Q on information available to us on the date of this Form 10-Q and we assume no obligation to update any such forward-looking statements, unless we are required to do so by applicable law. However, you are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with the Securities and Exchange Commission (“SEC”), including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.

The following discussion should be read in conjunction with our financial statements and related notes and other financial information appearing elsewhere in this report. In addition to historical information, the following discussion and other parts of this report contain forward-looking information that involves risks and uncertainties.

Overview

We are a specialty finance company focused on lending to middle-market companies. We are a closed-end, externally managed, non-diversified management investment company that has elected to be regulated as a BDC under the Investment Company Act of 1940, as amended (the “1940 Act”). Our primary business objectives are to generate current income and capital appreciation by investing primarily in senior secured loans with a first lien on collateral, including “unitranche” loans, which are loans that combine the characteristics of both first lien and second lien debt of U.S. middle-market companies. In addition, the Company intends to elect to be treated as a RIC for U.S. federal income tax purposes under Subchapter M of the Code for the tax period ending December 31, 2025 and intends to maintain its qualification as a RIC annually thereafter. For periods prior to the effectiveness of the RIC election, the Company expects to be taxed as a corporation for U.S. federal income tax purposes.

We generally define middle-market companies as those having earnings before interest, taxes, depreciation and amortization (“EBITDA”) of less than $150 million annually and we seek to achieve our investment objectives by:

(i)Accessing the loan origination channels developed by our team of experienced private credit investors, including our investment team and executive leadership;
(ii)Selecting investments within our core U.S. middle-market company focus;
(iii)Partnering with experienced private equity firms, sponsors or independent business owners, as well as a group of relationship lenders in so called “club deals” (which are generally investments that are either pre-marketed to a smaller group of relationship lenders, or lenders join together to provide the investment):
(iv)Implementing the disciplined underwriting standards established by the Adviser; and/or
(v)Drawing upon the aggregate experience and resources of the Adviser.

To accomplish this, the Company plans to make direct investments in portfolio companies that operate across various industries in U.S.-based companies. The Company may also selectively invest in (i) second lien and subordinated loans of, and warrants and minority equity securities in, U.S. middle-market companies, (ii) secondary purchases of assets or portfolios and (iii) distressed debt, debtor-in-possession loans, structured products, structurally subordinated loans, investments with deferred interest features, payment-in-kind (“PIK”) securities, zero-coupon securities and defaulted securities, but such investments are not the principal focus of its investment strategy. Our level of investment activity can and is expected to vary substantially from period to period depending on many factors, including the amount of debt available to middle-market companies, the general economic environment and the competitive environment for the types of investments we make.

We will seek to target a portfolio comprised primarily of first lien senior secured debt of U.S. middle market companies, with target hold size of approximately $10 million to $40 million. During our initial ramp-up period we may hold more concentrated positions and may deploy capital into temporary investments, including broadly syndicated loans. Our origination strategy focuses on leading the negotiation and structuring of the loans or securities in which we invest and holding the investments in our portfolio to maturity. In many cases, we will be the sole investor in the loan or security in our portfolio. Where there are multiple investors, we will generally seek to control or obtain significant influence over the rights of investors in the loan or security. We generally invest in securities that have been rated below investment grade by independent rating agencies or that would be rated below investment grade if they were

25

Table of Contents

rated. These securities, which are often referred to as “junk,” have predominantly speculative characteristics with respect to the issuer’s capacity to pay interest and repay principal. In addition, many of our debt investments have floating interest rates that reset on a periodic basis and typically do not fully pay down principal prior to maturity, which could increase our risk of losing part or all of our investment.

As of March 31, 2025 and December 31, 2024, our portfolio at fair value was comprised of the following:

March 31, 2025

December 31, 2024

Percentage of

Percentage of

 

    

Fair Value

    

Total Investments

    

Fair Value

    

Total Investments

 

Services: Business

$

26,561,639

23.7

%

$

33,684,779

36.9

%

Healthcare & Pharmaceuticals

 

22,279,786

 

20.0

%

22,530,197

 

24.7

%

Transportation: Cargo

 

16,542,520

 

14.8

%

 

%

Retail

 

10,681,412

 

9.6

%

 

%

Capital Equipment

 

10,461,022

 

9.4

%

10,539,169

 

11.6

%

FIRE: Insurance

 

9,030,488

 

8.1

%

9,053,321

 

9.9

%

FIRE: Finance

 

6,099,184

 

5.5

%

5,666,612

 

6.2

%

High Tech Industries

 

5,498,828

 

4.9

%

5,187,996

 

5.7

Media: Diversified & Production

 

4,480,895

 

4.0

%

4,526,128

 

5.0

%

Total

$

111,635,774

 

100.0

%

$

91,188,202

 

100.0

%

Our investment activities are managed by the Adviser and supervised by our board of managers (the “Board), of which a majority of the members are not “interested persons,” as defined in Section 2(a)(19) of the 1940 Act, of us, the Adviser and its affiliates.

Under an investment advisory agreement, or the Advisory Agreement, we have agreed to pay the Adviser a base management fee based on the sum of (1) the Members’ total unfunded Capital Commitments and (2) the Company’s total assets (excluding cash or cash equivalents but including assets purchased with borrowed amounts) as of the end of the most recently completed calendar quarter. In addition, the Adviser may also receive incentive compensation based on a percentage of out-performance above a Hurdle Rate on the Company’s income and a portion is based on a percentage of the Company’s capital gains. See Note 3 – Related Party Agreements – Advisory Agreement, for more information.

Under an administration agreement, or the Administration Agreement, we are provided with certain administrative services by an administrator, or the Administrator, which is currently Andalusian Credit Partners, LLC. Under the Administration Agreement, we have agreed to pay to the Administrator an annual administration fee of 0.25% on the Company’s total Capital Commitments, payable quarterly in arrears, for services and facilities provided under the Administration Agreement. See Note 3 – Related Party Agreements – Administration Agreement, for more information.

As of March 31, 2025, we have raised and received capital commitments of over $507.9 million of which $299.7 million was undrawn as of March 31, 2025. Since we began our investment activities in February 2024 through March 31, 2025, we have originated over approximately $170 million aggregate principal commitments to over 15 portfolio companies.

Macroeconomic Market Developments

The capital markets are subject to fluctuations caused by various external factors such as changes in the inflationary environment, interest rate movements, concerns over slowing economic growth and possible global recession, changes to U.S. tariff and import/export regulations, uncertainty and disruption caused by geopolitical events, including the conflicts in Ukraine, Russia, and the Middle East, among other factors. These macroeconomic developments are outside our control and could require us to adjust our plan of operations, and impact our financial position, results of operations or cash flows in the future. We monitor macroeconomic market developments and their related impact to our business, including impacts to our portfolio companies, employees, due diligence and underwriting processes, and the broader financial markets.

Our investment portfolio is currently focused on industries and sectors that are generally expected to be more resilient to U.S. and global economic cycles. This includes being partially insulated from declining interest rates as all of our floating rate debt investments, which represent 100.0% and 100.0% of our debt portfolio as of March 31, 2025 and December 31, 2024, respectively, are subject to interest rate floors. While our portfolio is not immune to the impact of macroeconomic events, we believe we and our portfolio are well positioned to manage the current environment. Given the unpredictability and fluidity of the macroeconomic market, neither our management nor our Board can predict the full impact of the macroeconomic events on our business, future results of operations,

26

Table of Contents

financial position, or cash flows. For additional information, see "Part I - Item 1A. Risk Factors" in our Form 10-K filed on March 19, 2025.

Portfolio Investment Activity

Our portfolio activity for the three months ended March 31, 2025 and 2024 was comprised of the following:

    

March 31, 2025

    

March 31, 2024

Investment Commitments

$

35,499,734

$

20,289,646

Investment Fundings:

 

  

 

  

New portfolio company

 

27,207,760

 

19,820,356

Existing portfolio company

 

837,742

 

Total Investment Fundings

$

28,045,502

$

19,820,356

Investment repayments

7,361,648

 

50,591

Total Net Investment Activity

$

20,683,854

$

19,769,765

The following table summarizes certain characteristics of our investment portfolio as of March 31, 2025 and December 31, 2024:

    

March 31, 2025

    

December 31, 2024

Number of investments

24

21

Number of portfolio companies

 

13

12

Percentage of total investment fair value

 

First-lien term loans

 

100.0

%

100.0

%

Percentage of debt investment fair value

 

Floating rate (1)

 

100.0

%

100.0

%

Fixed interest rate

 

%

%

Weighted Average Yield (2)

 

10.0

%

10.2

%

(1)

Primarily subject to interest rate floors.

(2)

Weighted average yield is calculated by weighting the yield to maturity of each investment by its ending funded par amount. Yield to maturity is calculated inclusive of a portfolio company’s spread, reference rate floor (if any) or actual reference rate in effect and original issue discount through maturity and excludes any upfront fees or present value adjustments.

The weighted average yield of our accruing debt and income producing securities will not be the same as a return on investment for our Members but, rather, relates to our investment portfolio and is calculated before the payment of all of our and any of our subsidiaries’ fees and expenses. The weighted average yield will be computed using the effective interest rates as of each respective date, including accretion of original issue discount and loan origination fees, but excluding investments on non-accrual status, if any. There can be no assurance that the weighted average yield will remain at its current level.

Portfolio Grading

In addition to various risk management and monitoring tools, our Adviser uses an investment grading system, which grades each investment on a scale of 1 to 4 no less frequently than quarterly in connection with our quarterly valuation process. This system is intended primarily to reflect the underlying risk of a portfolio investment relative to our initial cost basis in respect of such portfolio investment (e.g., at the time of origination or acquisition), although it may also take into account, under certain circumstances, the performance of the portfolio company’s business, the collateral coverage of the investment and other relevant factors. The grading system for our investments from 1 to 4, with 1 being the highest, is as follows:

Grade 1: Investments in portfolio companies whose performance is substantially within or above the Adviser’s expectations and whose risk factors are neutral to favorable to those at the time of the original investment or subsequent restructuring. All investments will initially be graded as a 1.

27

Table of Contents

Grade 2: Investments in portfolio companies whose performance is below the Adviser’s expectations and that require closer monitoring; however, the adverse impact may be deemed temporary, and the most likely outcome is that no loss of investment return (interest and/or dividends) or principal is expected.
Grade 3: Investments in portfolio companies whose performance is below the Adviser’s expectations and for which risk has increased materially since origination or subsequent restructuring. Some loss of investment return is likely, but no loss of principal is expected. Companies graded 3 generally present a higher risk of liquidity pressure and/or covenant breach over the next six to twelve months. These investments will be added to the Adviser’s “watch list.” Investment teams will research any areas of concern with the objective of early intervention with the company.
Grade 4: Investments in portfolio companies whose performance is materially below the Adviser’s expectations where business trends have deteriorated and risk factors have increased substantially since the original investment or subsequent restructuring, potentially resulting in a breach of covenants or other event of default. Investments graded 4 are those for which some loss of principal or invested capital is likely. For these investments, our investment teams review the loans on a bi-monthly basis and, where possible, pursue workout actions that achieve an early resolution to avoid further deterioration.

The following table shows the distribution of our outstanding debt investments on the 1 to 4 investment grading scale as of March 31, 2025 and December 31, 2024, respectively:

March 31, 2025

    

December 31, 2024

    

Investments

Percentage of

 

Investments

Percentage of

 

Investment Grade

    

at Fair Value

    

Total Investments

 

at Fair Value

    

Total Investments

 

1

$

98,621,388

 

88.3

%  

$

91,188,202

 

100.0

%  

2

 

13,014,386

 

11.7

 

 

3

 

 

 

 

4

 

 

 

 

Total

$

111,635,774

 

100.0

%  

$

91,188,202

 

100.0

%  

As of March 31, 2025 and December 31, 2024, our debt investments had a weighted average investment grading of 1.1 and 1.0 on a cost basis, respectively. Changes in a portfolio company's investment grading may be a result of changes in a portfolio company's performance and/or timing of expected liquidity events. For instance, we may downgrade a portfolio company if it is not meeting our financing criteria or are underperforming relative to their respective business plans. We may also downgrade a portfolio company as it approaches a point in time when it will require additional equity capital to continue operations. Conversely, we may upgrade a portfolio company's investment grading when it is exceeding our financial performance expectations and/or is expected to mature/repay in full due to a liquidity event. The overall downgrade of the portfolio's weighted average investment grading is reflective of the impact of the current macroeconomic environment.

As macroeconomic events evolve and cause disruption in the capital markets and to businesses, we are continuing to monitor and work with the management teams and stakeholders of our portfolio companies to navigate the significant market, operational, and economic challenges created by these events. This includes remaining proactive in our assessments of credit performance to manage potential risks across our investment portfolio.

28

Table of Contents

Non-accrual Investments

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected in full. When a Loan is placed on non-accrual status, the Company ceases to recognize interest income until the portfolio company has paid all principal and interest due or demonstrated the ability to repay its current and future contractual obligations to the Company. The Company may determine to continue to accrue interest on a loan where the investment has sufficient collateral value to collect all of the contractual amount due and is in the process of collection. Interest collected on non-accrual investments are generally applied to principal. As of March 31, 2025 and December 31, 2024, there were no loans placed on non-accrual status.

Results of Operations

The following table sets forth our financial data as of March 31, 2025 and December 31, 2024 and for the three months ended March 31, 2025 and 2024. The selected financial data has been derived from our unaudited financial statements, which are included elsewhere in this quarterly report on Form 10-Q.

    

Three months 

    

Three months

ended

ended

    

March 31, 2025

    

March 31, 2024

    

Statement of Operations Data

 

  

 

  

Income

 

  

 

  

Investment income

$

3,324,326

$

228,254

Expenses

 

Management and administration fees

 

1,865,353

1,687,707

Professional Fees

 

356,319

335,016

Interest expense and other financing costs

 

147,499

116,840

Other expenses

232,837

553,572

Total operating expenses

2,602,008

2,693,135

Management fee waiver

(240,951)

Net operating expenses

2,602,008

2,452,184

Net investment income (loss)

 

722,318

(2,223,930)

Net change in unrealized appreciation (depreciation)

 

(334,919)

Net increase (decrease) in net assets resulting from operations

$

387,399

$

(2,223,930)

Net increase (decrease) in net assets resulting from operations

 

Earnings per share – basic and diluted

$

0.04

$

(3.35)

March 31, 2025

December 31, 2024

Balance Sheet Data

Total return based on net asset value

0.26

%  

177.48

%

Net asset value per Share

$

15.22

$

15.18

Investments at fair value

111,635,774

91,188,202

Total assets

203,818,351

151,920,751

Total liabilities

2,323,210

2,171,474

Total net assets

201,495,141

149,749,277

29

Table of Contents

Investment Income

We generate revenue in the form of interest income and fees primarily from our debt investments. In some cases, our debt investments may pay PIK interest. Interest income for the three months ended March 31, 2025 totaled approximately $2.6 million as compared to approximately $0.2 million for the three months ended March 31, 2024. The increase in interest income from investments for the three months ended March 31, 2025 as compared to the three months ended March 31, 2024 is primarily attributable to an increase in the weighted average principal held during the period.

Interest income on cash and cash equivalents primarily relates to cash held in money market accounts, which for the three months ended March 31, 2025 totaled approximately $0.7 million as compared to approximately $0.1 million for the three months ended March 31, 2024. Cash is held for investment purposes and as needed held to ensure the portfolio remains in compliance with RIC diversification requirements.

Operating Expenses

Our operating expenses are comprised of management and administration fees, professional fees, interest and other financing fees, offering expenses, and general and administrative expenses. During the three months ended March 31, 2025 and 2024, our operating expenses totaled approximately $2.6 million and $2.5 million, respectively.

Management, Incentive, and Administration fees

During the three months ended March 31, 2025 and 2024, management fees totaled approximately $1.5 million and $1.4 million, respectively. Management fees increased primarily due to our increase in capital commitments. During the three months ended March 31, 2024, $0.2 million of management fees were waived pursuant to the waiver election which ended in November 2024. There were no incentive fees for the three months ended March 31, 2025 and 2024. See Note 3 – Related Party Agreements – Advisory Agreement, for additional discussion related to management and incentive fees.

During the three months ended March 31, 2025 and 2024, administration fees totaled approximately $0.3 million and $0.2 million, respectively. Administration fees increased primarily due to our increase in capital commitments. See Note 3 – Related Party Agreements – Administration Agreement, for additional discussion related to administration fees.

Professional Fees

Professional fees include legal, audit, tax, valuation and other professional fees incurred related to the management of the Company. During the three months ended March 31, 2025 and 2024, professional fees totaled approximately $0.4 million and $0.3 million, respectively for the three-month periods. Professional fees increased primarily due to an increase in valuation expenses.

Interest and Other Financing Expenses

Interest and other financing expenses relates to interest and costs associated with our CIBC Credit Facility. During the three months ended March 31, 2025 and 2024, interest expenses totaled approximately none and $10.8 thousand, respectively. During the three months ended March 31, 2025 and 2024, other financing costs totaled approximately $147.5 thousand and $106.0 thousand, respectively.

There were no borrowings outstanding for the three months ended March 31, 2025. For the three months ended March 31, 2024, average borrowings outstanding were approximately $0.5 million and the weighted average interest rate (excluding unused fees and financing costs) of the aggregate borrowings outstanding was 8.32%. See Note 6 – Borrowings, for more information.

Other Expenses

Other expenses include board fees and certain allocated technology, research, and other regulatory and compliance expenses incurred related to the management of the Company. During the three months ended March 31, 2025 and 2024, other expenses totaled approximately $0.2 million and $0.6 million, respectively.

30

Table of Contents

Other expenses also include offering expenses. During the three months ended March 31, 2025, there were no additional offering expenses incurred. During the three months ended March 31, 2024, offering expenses totaled approximately $0.3 million. The Company will pay all initial organizational and offering expenses associated with the Private Offering of its Shares up to a maximum amount of 1.50% of aggregate Capital Commitments to the Company over the initial four-year period following November 14, 2023. Since inception through March 31, 2025, the Company has incurred $2.2 million of organizational and offering expenses.

Income Taxes, Including Excise Taxes

We intend to elect to be treated as a RIC under Subchapter M of the Code for the tax period ending December 31, 2025 and intend to maintain qualification as a RIC annually thereafter. To qualify for tax treatment as a RIC, we must, among other things, distribute to our Members in each taxable year generally at least 90% of our investment company taxable income, as defined by the Code, and net tax-exempt income, if any for that taxable year. To maintain our tax treatment as a RIC, we, among other things, intend to make the required distributions to our Members, which generally relieves us from U.S. federal income taxes at corporate rates to the extent of such distributions. For periods prior to the effectiveness of our RIC election, we expect to be taxed as a corporation. It is not anticipated that we will incur U.S. federal, state, and local taxes (other than nominal state and local taxes) as a corporation and consequently, no such taxes were accrued for the three months ended March 31, 2024.

Upon our qualification as a RIC, depending on the level of taxable income earned in a tax year, we can be expected to carry forward taxable income (including net capital gains, if any) in excess of current year dividend distributions from the current tax year into the next tax year and pay a nondeductible 4% U.S. federal excise tax on such taxable income, as required. To the extent that we determine that our estimated current year annual taxable income will be in excess of estimated current year dividend distributions from such income, we will accrue excise tax on estimated excess taxable income.

The character of income and gains that the Company distributes is determined in accordance with U.S. income tax regulations that may differ from GAAP. Book and tax basis differences relating to Member dividends and distributions and other permanent book and tax differences are reclassified to paid-in capital.

Net Change in Unrealized Appreciation and Depreciation

The net change in unrealized appreciation and depreciation of our investments is derived from the changes in fair value of each investment determined in good faith by the Adviser, in its capacity as our valuation designee under rule 2a-5 under the 1940 Act, in accordance with valuation policies and procedures that were approved by the Board. The following table summarizes the change in net unrealized appreciation or depreciation of investments for the three months ended March 31, 2025 and 2024:

    

March 31, 2025

    

March 31, 2024

Investment valuation appreciation (depreciation)

$

(329,874)

$

Reversal of prior period net change in unrealized (appreciation) depreciation upon a realization event

(5,045)

Total Net change in unrealized appreciation (depreciation)

$

(334,919)

$

For the three months ended March 31, 2025, the net change in unrealized depreciation was primarily related to depreciation of our debt investments due to an increase in market discount rates.

31

Table of Contents

Financial Condition, Liquidity and Capital Resources

Our liquidity and capital resources are derived from investor drawdowns, debt borrowings and cash flows from operations, including investment sales and repayments, and income earned. Our primary use of funds from operations includes investments in portfolio companies and payments of fees and other operating expenses we incur.

We have used, and expect to continue to use, the proceeds from the turnover of our portfolio and from private offerings of shares to finance our investment objectives. We may also raise additional equity or debt capital through private offerings of securities, by securitizing a portion of our investments. As noted in Note 1. Organization, we are conducting, on a continuous basis, a private offering of our limited liability company interests, at par value $0.001 per share, to accredited investors, as defined in Regulation D under the Securities Act in reliance on exemptions from the registration requirements of the Securities Act. Shares are offered for subscription continuously, pursuant to the terms set forth in our Memorandum. This “Financial Condition, Liquidity and Capital Resources” section should be read in conjunction with the “Macroeconomic Market Developments” section above.

As of March 31, 2025, the Company had received Capital Commitments of $507.9 million of which $299.7 million was undrawn. As of December 31, 2024, the Company had received Capital Commitments of $505.7 million of which $348.9 million was undrawn.

There were no dividends declared or reinvested from inception through March 31, 2025.

During the three months ended March 31, 2025, we principally funded our operations from (i) cash receipts from interest and fee income from our investment portfolio, (ii) cash proceeds from the realization of portfolio investments through the repayments of debt investments, and (iii) drawdowns from unfunded equity commitments.

During the three months ended March 31, 2025, our operating activities used $20.1 million of cash and cash equivalents, compared to $21.2 million used during the three months ended March 31, 2024. The $1.1 million decrease in cash used in operating activities was primarily due to increased interest income generated from operations of approximately $3.0 million offset by  an increase in purchases of investments net of principal repayments of $0.9 million.

During the three months ended March 31, 2025, our financing activities provided $51.4 million of cash, compared to $21.5 million provided during the three months ended March 31, 2024. The $29.9 million increase in cash flows from financing activities was primarily the result of increased proceeds from issuances of shares during the three months ended March 31, 2025 compared to the three months ended March 31, 2024.

Available liquidity and capital resources as of March 31, 2025

As of March 31, 2025, we had $90.7 million of cash and cash equivalents, and $75.0 million of availability under the CIBC Credit Facility. As of March 31, 2025, we believed we had adequate financial resources to satisfy unfunded portfolio company commitments of $29.2 million and ample liquidity to support our near-term capital requirements. As the impact of macro-economic events, potential global recession, acts of terrorism, war, geopolitical events, and the related disruption to markets and business continues to impact the economy, we will continue to evaluate our overall liquidity position and take proactive steps to maintain the appropriate liquidity position based upon the current circumstances. The 1940 Act permits BDCs to incur borrowings, issue debt securities, or issue preferred stock unless immediately after the borrowings or issuance the ratio of total assets (less total liabilities other than indebtedness) to total indebtedness plus preferred stock is less than 200% (or 150% if certain requirements are met). On August 1, 2023, the Company received approval from ACP, as the Company’s sole initial shareholder, for the application of the modified asset coverage requirements set forth in Section 61(a)(2) of the 1940 Act, as amended by the Small Business Credit Availability Act. As a result, effective on August 2, 2023, the Company’s asset coverage requirement applicable to senior securities was reduced from 200% to 150%.

32

Table of Contents

Share Issuances

As of March 31, 2025, the Company had the authority to issue an unlimited number of Shares at $0.001 par value per share.

Since inception through March 31, 2025, the Company has completed the following share issuances:

    

    

 

Average Issuance

Share Issuance Date

Shares Issued

Proceeds Received

Price per Share

June 30, 2023

50

$

1,000

$

20.00

November 14, 2023

171,824

3,436,474

20.00

February 13, 2024

973,655

19,473,102

20.00

April 15, 2024

2,482,469

38,892,227

15.67

September 3, 2024

2,901,546

44,013,319

15.17

December 2, 2024

3,333,813

50,542,802

15.16

March 3, 2025

3,375,974

51,358,465

15.21

Total

13,239,331

$

207,717,389

$

15.69

The sales of the Shares were made pursuant to subscription agreements entered into by the Company with its investors, as described in “Note 8. Net Assets” in the notes to our financial statements and appearing elsewhere in this report. As of March 31, 2025 and December 31, 2024, the Company had 13,329,331 and 9,863,357 Shares outstanding, respectively.

Commitments and Obligations

In the normal course of business, we are party to financial instruments with off-balance sheet risk. These consist primarily of unfunded contractual commitments to extend credit, in the form of loans, to our portfolio companies. Unfunded contractual commitments to provide funds to portfolio companies are not reflected on our balance sheet.

As of March 31, 2025 and December 31, 2024, the Company had the following unfunded commitments:

Par as of

Company

    

March 31, 2025

    

December 31, 2024

A. Stucki Company

$

6,069,197

$

Allworth Financial Group, L.P.

5,078,390

5,547,836

Allworth Financial Group, L.P.

 

261,268

261,268

Komline-Sanderson Group, Inc.

 

5,218,858

 

5,218,858

Komline-Sanderson Group, Inc.

 

2,124,366

 

2,124,366

NPM Franchising, LLC

 

1,820,035

OneZero

608,958

918,686

OneZero

656,204

656,204

Pediatric Home Respiratory Services, LLC

2,730,052

2,730,052

Pediatric Home Respiratory Services, LLC

1,274,025

1,274,025

StrategyCorps, LLC

2,274,436

2,274,436

StrategyCorps, LLC

1,080,357

1,137,218

Total (1)

$

29,196,146

$

22,142,949

(1) The Adviser’s determination of the fair value of the current investments in these portfolio companies includes an analysis of the fair value of any unfunded commitments.

Related Party Transactions

As detailed in Note 3. Related Party Transaction, appearing elsewhere in this report, we have entered into a number of business relationships with affiliated or related parties, including the Advisory Agreement and the Administration Agreement.

In addition to the aforementioned agreements, the Company has received an exemptive order from the SEC that permits the Company, Adviser and certain of its affiliates to co-invest with other funds managed by the Adviser and its affiliates in a manner consistent with our investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors.

33

Table of Contents

Critical Accounting Policies

The preparation of our financial statements and related disclosures in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the periods reported. On an ongoing basis, management evaluates its estimates and assumptions, which are based on the information that is currently available to them, historical experience and on various other inputs and assumptions that it believes to be reasonable under the circumstances. Actual results could differ materially from those estimates under different assumptions or conditions. For a description of our critical accounting policies, refer to “Note 2. Summary of Significant Accounting Policies” included in the notes to our financial statements appearing elsewhere in this report. We consider the most significant accounting policies to be those related to our Valuation of Investments, Fair Valuation Measurements, and Income Recognition. The valuation of investments is our most significant critical estimate. The most significant input to this estimate is the discount interest rate, which includes the hypothetical market yield plus premium or discount adjustment, used in determining the fair value of our debt investments.

Item 3.Quantitative and Qualitative Disclosures About Market Risk.

We are subject to financial market risks, including changes in interest rates. A rise in the general level of interest rates can be expected to lead to higher interest rates applicable to the variable rate investments we may hold and to declines in the value of any fixed rate investments we may hold. A rise in interest rates would also be expected to lead to higher cost on any floating rate borrowings we may have in the future.

We intend to fund portions of our investments with borrowings, and at such time, our net investment income will be affected by the difference between the rate at which we invest and the rate at which we borrow. Accordingly, we cannot assure you that a significant change in market interest rates will not have a material adverse effect on our net investment income. In a low interest rate environment, the difference between the total interest income earned on interest earning assets and the total interest expense incurred on interest bearing liabilities may be compressed, reducing our net income and potentially adversely affecting our operating results. Conversely, in a rising interest rate environment, such difference could potentially increase thereby increasing our net income as indicated per the table below.

As of March 31, 2025, 100.0% of our debt investments based on fair value bear interest at floating rates. Additionally, the weighted average reference rate floor, based on fair value, of our debt investments was 1.28%. The CIBC Credit Facility bears interest at floating rates with no interest rate floor.

Based on our Statements of Assets and Liabilities as of March 31, 2025, assuming there are no changes in our investment and borrowing structure, the following table shows the approximate annualized impact on net interest income, of hypothetical base rate changes in interest rates (considering interest rate floors for floating rate instruments):

Basis Point Change

    

Interest Income

    

Interest Expense

    

Net Interest Income

Up 300 basis points

$

3,389,348

$

$

3,389,348

Up 200 basis points

 

2,259,565

2,259,565

Up 100 basis points

 

1,129,783

1,129,783

Down 100 basis points

 

(1,129,783)

(1,129,783)

Down 200 basis points

 

(2,259,565)

(2,259,565)

Down 300 basis points

 

(3,389,348)

(3,389,348)

We may in the future hedge against interest rate fluctuations by using hedging instruments such as additional interest rate swaps, futures, options, and forward contracts. While hedging activities may mitigate our exposure to adverse fluctuations in interest rates, certain hedging transactions that we may enter into in the future, such as interest rate swap agreements, may also limit our ability to participate in the benefits of lower interest rates with respect to our portfolio investments.

34

Table of Contents

Item 4.Controls and Procedures

(a)Evaluation of Disclosure Controls and Procedures

In accordance with Rules 13a-15(b) and 15d-15(b) of the Exchange Act, we, under the supervision and with the participation of our Chief Executive Officer and Principal Financial Officer, carried out an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) of the Exchange Act) as of the end of the period covered by this Quarterly Report on Form 10-Q and determined that our disclosure controls and procedures are effective as of the end of the period covered by the Quarterly Report on Form 10-Q.

(b)Changes in Internal Controls Over Financial Reporting

There have been no changes in our internal controls over financial reporting that occurred during the quarter ended March 31, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

35

Table of Contents

PART II. OTHER INFORMATION

Item 1.Legal Proceedings.

Neither we nor the Adviser are currently subject to any material legal proceedings, nor, to our knowledge, are any material legal proceeding threatened against us. From time to time, we may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of our rights under contracts with our portfolio companies. Our business is also subject to extensive regulation, which may result in regulatory proceedings against us. While the outcome of any such future legal or regulatory proceedings cannot be predicted with certainty, we do not expect that any such future proceedings will have a material effect upon our financial condition or results of operations.

Item 1A. Risk Factors.

In addition to other information set forth in this report, you should carefully consider the risk factors discussed in Part I, “ITEM 1A. RISK FACTORS” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, which could materially affect our business, financial condition, and/or operating results. The risks described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially and adversely affect our business, financial condition and/or operating results.

There have been no material changes since the filing of the Company’s Annual Report on Form 10-K with the SEC on March 19, 2025 to the risk factors previously disclosed therein. If any of such risks actually occur, our business, financial condition or results of operations could be materially adversely affected. If that happens, the value of our securities could decline, and you may lose all or part of your investment.

Item 2.Unregistered Sales of Equity Securities and Use of Proceeds.

Except as previously reported by the Company on its current reports on Form 8-K, the Company did not sell any securities during the period covered by this Quarterly Report on Form 10-Q that were not registered under the Securities Act.

The Company did not repurchase any of its equity securities during the three months ended March 31, 2025.

Item 3.Defaults Upon Senior Securities.

None.

Item 4.Mine Safety Disclosures.

Not applicable.

36

Table of Contents

Item 5.Other Information

Resignation of Principal Financial Officer; Appointment of Chief Financial Officer

On May 13, 2025, the Board accepted Mike Szczurek’s resignation as Principal Financial Officer of the Company, effective as of the close of business on May 16, 2025.

On May 13, 2025, the Board appointed Moses Awe as Chief Financial Officer of the Company, effective as of the close of business on May 16, 2025.

Mr. Awe is the Chief Financial Officer of Andalusian Credit Partners (“ACP”). Prior to joining Andalusian, Mr. Awe was the Controller for Hercules Capital, Inc.’s private funds and investment advisor. He also operated as the Senior Director of Finance for Hercules Capital, Inc., a publicly listed, internally managed, BDC specializing in venture debt. Prior to Hercules, Mr. Awe was a Director at PricewaterhouseCoopers, LLP, where he specialized in BDCs, asset managers, and private wealth funds, servicing clients in New York and London. Mr. Awe is a CPA in New York and Texas. Mr. Awe graduated with Honors from the University of Texas at Austin with a Master in professional accounting, Bachelor of Business Administration, and B.A. in German.

There is no arrangement or understanding between Mr. Awe and any other person pursuant to which he was appointed as Chief Financial Officer. Further, with regard to Mr. Awe, there are no transactions since the beginning of the Company’s last fiscal year, or any currently proposed transaction, in which the Company is a participant that would require disclosure under Item 404(a) of Regulation S-K promulgated by the SEC.

Rule 10b5-1 Trading Plans

During the fiscal quarter ended March 31, 2025, none of the Company’s managers or executive officers adopted or terminated any contract, instruction or written plan for the purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement.”

37

Table of Contents

Item 6.Exhibits

Number

    

Exhibit

3.1

 

Amended and Restated Limited Liability Company Agreement (incorporated by reference to Exhibit 3.3 to Amendment No. 1 to the Company’s Registration Statement, filed on December 22, 2023).

31.1

 

Chief Executive Officer Certification Pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

31.2

 

Principal Financial Officer Certification Pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

32.1

 

Chief Executive Officer Certification pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**

32.2

Principal Financial Officer Certification pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**

101.INS

Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because

XBRL tags are embedded within the Inline XBRL document.*

101.SCH

Inline XBRL Taxonomy Extension Schema Document*

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document*

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document*

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document*

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document*

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)*

*

Filed Herewith.

**

Furnished Herewith.

38

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Andalusian Credit Company, LLC 

Date: May 14, 2025

By:

/s/ Aaron Kless

Aaron Kless

Chief Executive Officer

(Principal Executive Officer)

Date: May 14, 2025

By:

/s/ Mike Szczurek

Mike Szczurek

Principal Financial Officer

39